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Abstract
Despite decades of the implementation of the directly observed therapy short-course
(DOTS), Sierra Leone is ranked among the 30 highest TB-burdened countries. Several
factors account for unfavorable treatment outcomes, among which are patient
characteristics. Previous studies have only focused on treatment compliance without any
consideration for the factors that lead to noncompliance to treatment. The purpose of this
study was to investigate patient characteristics that are associated with treatment
noncompliance (treatment not completed) among TB patients undergoing the DOTS
program in Sierra Leone. A retrospective longitudinal quantitative design was used to
analyze secondary data from the completed records of 1,633 TB patients, using the
Andersen’s behavioral model of health services utilization as a theoretical framework
work. Descriptive statistics and bivariate and multivariate logistic regressions were used
to analyze the data. The results show that there was no significant association between
treatment completion and age, gender, and TB-case category. On the other hand, being
HIV-positive decreases the odds of treatment completion. Also, the educational level,
geographic location, and year of treatment were significantly associated with treatment
completion. Overall, program performance improved as the number of dropouts
decreased significantly between 2013 and 2015. The social change implication of this
study was that it identified HIV-positive patients and rural communities as areas needing
specific attention such as the assignment of case managers to ensure compliance thereby
improve DOTS program performance, thereby reducing the incidence and transmission
of TB.
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Chapter 1: Introduction to the Study
Introduction
Tuberculosis is a major global public health threat despite tremendous efforts to
treat and control the disease using affordable drugs (Anuwatnonthakate et al., 2008). In
2014 alone, about 9,600,000 people were said to be infected with TB (World health
Organization, [WHO], 2015). It is the second most deadly disease in the world,
accounting for 1,500,000 deaths worldwide in 2014 (WHO, 2015). All told, tuberculosis
affects about 2 billion people worldwide (Gordin & Masur, 2012; WHO, 2015).
Tuberculosis remains one of the most infectious and deadly diseases in Sierra
Leone. The number of reported tuberculosis cases had almost doubled since the
declaration of a millennium development goal in the year 2000 from 6,737 in 2005 to
12,477 in 2014 (WHO, 2015). Sierra Leone is among the 30 countries with the highest
burden of TB with at least 10,000 cases per year (WHO, 2015). According to WHO
(2016), the total number of deaths from tuberculosis in Sierra Leone reached a high of
8,131 in 2014, accounting for 8.6% of the number of total deaths in the country. The ageadjusted death rate from tuberculosis is 230.17 per 100,000 people, which places Sierra
Leone in the unenviable position of ranking number one in the world (WHO, 2016).
It has been reported that the continued rise in the incidence of TB can be
attributed to a number of factors such as poverty, overcrowding, unavailability of drugs,
drug resistance, and poor compliance (Ministry of Health and Sanitation [MOHS], 2010).
There is increased concern that TB/HIV comorbidity and the emergence of multidrug
resistant TB will exacerbate an already high TB mortality rate in the country (MOHS,
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2010). The continued upward trajectory of TB rates makes it urgent to mount sustained
efforts to continue the fight against the disease. The interplay of several risk factors both
structural, such as type of housing, overcrowding, and homelessness (Garfein et al.,
2010), and individual risk factors such as smoking (Horne et al., 2012), age (Syed, 2014),
HIV coinfection (Garfein et al., 2010; Kendall, 2012), and multidrug resistance (Kendall,
2012) has influenced this trajectory. There is a need for the understanding of these forces
by both policy makers and healthcare givers in order to slow down the trajectory.
However, to my knowledge no study has been conducted to explain the contribution of
patient characteristics that are associated with noncompletion of TB treatment in Sierra
Leone. Therefore, the purpose of this research was to investigate the effect of patient
characteristics on the completion of TB treatment among patients enrolled in the directly
observed therapy short-course (DOTS) program in Sierra Leone. My aim was to find out
whether there is a relationship between treatment completion and patient’s age, gender,
HIV status, and TB category. An understanding of such relationship will help policy
makers and healthcare providers develop strategies to target such groups and improve on
treatment completion rate.
In this chapter, I will briefly present a background review of the topic, focusing
on the gap that exists in the literature. I will then explain the problem statement, the
purpose of the study, the research questions, the hypothesis that I proposed, and provide a
brief discussion of the theoretical framework which this study was grounded on. I will
endeavor to define key terms as they apply to this research and state the limitations and
assumptions of the study. In the chapter, I will also describe the scope and the boundaries
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of the research. It will conclude with a section on the potential contributions of the study
to program implementation and success, applicability to treatment guidance, policy
formulation, and its overall potential for creating social change.
Background of the Study
TB is a contagious disease caused by the microorganism Mycobacteria
tuberculosis (Butler & Carr, 2013; Driver, Matus, Bayuga, Winters, & Munsiff, 2005;
Kendall, 2012). It is among the oldest diseases known to affect humans (Driver et al.,
2005). TB is a chronic disease that affects the lungs (pulmonary tuberculosis), but can
also affect other parts of the body (extrapulmonary TB) such as the brain, kidneys, bones,
and spine (Kendall, 2012). The disease is transmitted from one person to another through
droplet infections (Kendall, 2012).
The majority of people infected with TB remain largely asymptomatic; they are
not infectious and cannot transmit the disease to other people (Center for Disease Control
and Prevention [CDC], 2012). The people who carry the infection without manifesting
any clinical symptoms have a latent TB infection (LTBI; CDC, 2013). When healthy,
they do not transmit the disease to other people in their environment. The infection is
kept under control by the body’s immune system. However, about 10% of those infected
with LTBI may develop the full-blown disease in their lifetime, known as TB disease or
active TB (Gordin & Masur, 2012). This is especially common in persons with a
weakened immune system such as HIV/AIDS patients (Gordin & Masur, 2012).
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TB Disease/Active TB
A congruence of factors both personal and environmental may influence the
progression of LTBI to active TB disease. People with LTBI who have come into contact
with active TB patients and had been recently infected (within 2 weeks) are most likely to
develop active TB (CDC, 2016). Other people develop the disease over a long time after
their immune systems have been compromised. It is believed that infection with
HIV/AIDS, chronic renal failure, and diabetes accelerates LTBI to active TB disease
(CDC, 2016; Gordin & Masur, 2012). Generally, the people with higher risk of
developing full-blown TB are immunocompromised patients such as those with HIV,
children under 5 years of age, and institutionalized persons such people living in
homeless shelters and injection drug users (CDC, 2016). Healthcare workers working
with at-risk patients are also at increased risk of contracting the infection, especially in
developing countries where attention to infection controls is less rigid (CDC, 2016).
Symptoms
The majority of people with TB infection do not show any signs and symptoms
(CDC, 2016). Some of the symptoms of active TB are common to other diseases and may
be different depending on the organ that is being affected (CDC, 2016). It is imperative
that TB diagnosis is based not just on clinical symptoms but backed by at least one TB
test (CDC, 2016). Patients with active pulmonary TB disease experience a prolonged
cough lasting more than 2 weeks, chest pain, shortness of breath, and sometimes
coughing up blood or phlegm from deep down in the lungs (hemoptysis; CDC, 2016. The
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patient may also experience recurrent fever, chills, loss of appetite, weight loss, and night
sweats (CDC, 2016).
Diagnosis
The Mantoux tuberculin skin test, or simply TB skin test, and the interferongamma release assay (IGRA) blood test, are the two main methods used to screen for TB
infection (CDC, 2016). Additional tests such as smear microscopy, chest radiography,
lymph node biopsy, and blood fluid examination are performed to confirm the presence
of TB disease (CDC, 2016.
The TB skin test contains tuberculin purified protein derivative, which when
injected under the skin elicits a delayed immune response in TB infected patients (WHO,
2016). This can be detected by the appearance of a circular swelling around the point of
injection, and the result of the test can be interpreted within 48 to 72 hours (CDC, 2016).
The size of the swelling determines whether the person is positive or negative. A negative
result indicates that the person did not have the bacteria; however, a positive result
indicates that the person has been exposed to the bacteria but does not necessarily have
active TB disease (CDC, 2016).
The IGRA is a blood test that is also used for diagnosing TB. There are two types
of IGRA used: QuantiFERON TB Gold and the T-Spot TB tests (CDC, 2016). The blood
test detects cytokines released by a person’s immune response in response to the presence
of TB bacteria in the blood of the infected (CDC, 2016).
In both cases, the tests do not differentiate between LTBI and active infection.
The TB skin test often gives false positive results to those who have been vaccinated with
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Bacillus Calmette–Guérin (BCG) vaccine for TB prevention. BCG vaccine is
administered in highly endemic countries (CDC, 2016). Further tests are required with
support from clinical expressions to confirm active infection.
Sputum smear microscopy. Sputum smear microscopy is the gold standard used
for the diagnosis of TB in countries with high rates of TB infection. In 2012, the WHO
recommended the collection of two specimens from patients on the same day for sputum
smear microscopy (Kirwan, 2012). The Ziehl-Neelsen acid-fast staining technique is used
to detect the presence of TB bacteria under a microscope (Gordin & Masur, 2012). The
technique is inexpensive, and results can be obtained within hours. The disadvantage of
the system is its low sensitivity, with a detection rate of 30% to 60% (Gordin & Masur,
2012). The sputum smear TB test has been augmented by the use of fluorescent
microscopy to increase the detection rate (Gordin & Masur, 2012).
Culture and chest x-ray. TB can be diagnosed by the use of X-ray and cultural
techniques. Culturing the bacteria in an enrichment broth significantly increases the
quantity of the bacteria, making it easier to detect (Gordin & Masur, 2012). Culturing is
also used to test for susceptibility of the bacteria to known anti-TB drugs. It can also help
to identify whether an individual has naïve mycobacteria or has developed a resistant
species causing multidrug resistant (MDR) TB or extensively drug resistant (XDR) TB
discussed later in this section. The use of culturing techniques for resource-poor nations
such as Sierra Leone is challenging as it requires complex, expensive equipment beyond
the reach of those nations. It also takes a longer time to arrive at a conclusive diagnosis.
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Extra-pulmonary TB (EPTB) diagnosis. The method of choice for the diagnosis
of EPTB disease is the use of histopathology and microscopic staining techniques
(Purohit & Mustafa, 2015). In this method, a biopsy of the lymph node or lungs is
performed to excise a minute portion of the affected organ, and the pieces are then
stained and histologically analyzed (Purohit & Mustafa, 2015). The presence of
granulomatous inflammation in the affected area and some Langhan’s giant cells are
indicative of TB disease (Purohit & Mustafa, 2015). Fine needle aspiration cytology can
also be performed to examine body fluids such as cerebrospinal fluids and pleural fluids
for EPTB disease (Purohit & Mustafa, 2015).
Treatment
The aim of a TB treatment program is four-fold: cure the patient, prevent relapse,
reduce transmission, and prevent the development of drug resistance. The objective of the
short course intense drug regimen is to deliver rapid bactericidal activity and provide
sterilizing effect and suppression of the development of acquired drug resistance TB
(Pasipanodya & Gumbo, 2013). For these reasons, both LTBI and active TB patients
should be treated. The use of a combination of multiple antimicrobial TB drugs is more
efficient in treating the bacteria than single-dose drugs (Elkomy, Awad, El-Shora, &
Elsherbeni, 2013). The commonly used first-line drug of choice for new patients are
isoniazid (INH) rifampicin (RMP), pyrazinamide, ethambutol, and sometimes
streptomycin (Elkomy, Awad, El-Shora, & Elsherbeni, 2013). The treatment phase is
divided into 2 months (56 doses) of high-intensity chemotherapy with INH, RMP,
pyrazinamide, and ethambutol (Elkomy, Awad, El-Shora, & Elsherbeni, 2013). The next
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phase is the continuation phase which lasts for 4 or 7 months, involves low-intensity
treatment with INH and rifampicin RMP, depending on the patient’s circumstance
(Elkomy et al., 2013). The majority of the patients whose sputum smear converts to
negative after intensive treatment continue their treatments for 4 months more (156
doses; (CDC, 2016). While those whose sputum smear remains positive after the
intensive phase will continue their treatment for 7 more months (CDC, 2016).
The under-treatment and noncompliance to a TB treatment regimen leads to the
development of multidrug-resistant TB (MDR-TB) (Getahun, Ameni, Medhin, &
Biadgilign, 2013). MDR-TB can also be acquired by coming into close contact with
MDR-TB patients in highly populated areas, such as hospitals, prison facilities, or
shelters for the homeless (CDC, 2016). MDR-TB develops when the TB bacteria are
resistant to the two common first-line TB drugs: INH and RMP. In cases where the
bacteria are resistant to INH and RMP, as well as at least three of the six classes of the
second line anti-TB drugs, the situation is described as XDR-TBCDC, 2016). Treatment
of patients with MDR-TB and XDR-TB is complex, as the individual does not respond to
the most commonly available TB drugs. The emergence of MDR-TB is alarming, and is a
major challenge to TB treatment programs around the world. It is estimated that about
480,000 people had MDR-TB and 190,000 MDR-TB deaths were recorded in 2014
worldwide (WHO, 2016).
Directly Observed Therapy Short-Course (DOTS) vs. Self-Administered Therapy
There are two general methods of medication administration to TB patients.
Because a course of long-term treatment is required, some patients receive their
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medication supplies and self-administer their medications for the duration of the
treatment, referred to as self-administration therapy (Anuwatnonthakate et al., 2008).
Other patients receive their treatment through the WHO-recommended DOTS program
(Anuwatnonthakate et al., 2008).
DOTS is an internationally recognized treatment protocol that is part of the WHO
STOP Strategy for the treatment of TB (Elkomy et al., 2013). The success of DOTS in
increasing compliance, reducing the number of new cases, and preventing the
development of drug-resistant TB has been widely applauded (Elkomy et al., 2013;
Obasanjo, Shields, Coggin, Chaisson, & Glass, 2012). The strategy is comprised of five
components: political commitment by national governments, improved laboratory
facilities with quality sputum-smear microscopy capabilities, regular supply of anti-TB
drugs, direct observation by a health care worker of each patient swallowing their
medications, and a standardized recording and reporting system for patient and program
success (Pasipanodya & Gumbo, 2013). The proportion of patients’ loss-to-follow-up
(LTFU) was substantially reduced following successful implementation of DOTS
(Obasanjo et al., 2012). As a consequence, the treatment resulted in a reduction in the
total number of cases after DOTS among patients followed during a study in Baltimore
(Obasanjo et al., 2012).
In a similar study conducted in Thailand, Anuwatnonthakate et al. (2008) found
that 2 months of intense DOTS was strongly associated with improved TB treatment
outcomes. The researchers found that the greatest effect was realized among patients who
were monitored by a healthcare worker compared with those who were monitored by
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their family members. DOTS had a greater effect on reducing default rate among TB
patients in the study as well. These results were consistent with similar findings by
Pungrassami et al. (2002), who observed that patients who were monitored by health care
personnel had the greater chances of abiding to their DOT treatment regimen compared
with self-administration, which was found to have the highest risk of not complying with
their treatment regimen.
DOTS has a significant effect on the treatment success rate in countries that have
full DOTS coverage with at least 18% success rate after the implementation of DOTS
(Elkomy et al., 2013). Elkomy et al. (2013) recorded 70% regularity among patients
receiving their TB medications through DOTS compared with 40% of patients who are
self-administered. The authors cited the characteristics of the patient, availability of
drugs, communication between patients and their caregivers, side effects, duration and
number of medications needed, and economic status of the patient as reasons for poor
adherence.
Even though the success of DOTS has been lauded in many quarters, there are
still some mixed results regarding its outcome (Anuwatnonthakate et al., 2008). Many
studies that were important in the adoption of DOTS were done retrospectively or utilized
quasi-experimental designs. In a prospective study, Volmink and Garner (2007) did not
find any major difference between DOT and self-administered therapy in terms of cure
rate and treatment completion among both active and latent TB patients. There was also
no significant difference in recurrence between DOT and self-administered therapy
patients (Cox, Morrow, & Deutschmann, 2008). In fact, in some high TB-burdened
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countries, such as South Africa, 77% of all recurrences were due to new infections rather
than relapse (Charalambous et al., 2008).
Problem Statement
Even though Sierra Leone adopted the WHO-recommended DOTS for the
treatment of TB in 1990, the TB burden continues to increase with an estimated
prevalence of 574 per 100,000 populations (WHO, 2014). The number of registered TB
cases in Sierra Leone almost doubled between 2004 and 2007 (National Leprosy and
Tuberculosis Program, 2010). The success rate of TB treatment increased from 79% in
2004 to the high of 86% in 2009, but decreased back down to 79% in 2010 (WHO, 2014).
The incidence rate of TB has increased from 252 in 1990 to 310 per 100,000 people in
2014 (WHO, 2016). The fluctuations in the success rate were attributed to lack of
compliance with the treatment regimen, lack of drug supply, and the possible
development of drug-resistant TB (WHO, 2014).
The current focus of research on the implementation of DOTS in Sierra Leone has
been on trends in the success rate of the DOTS program (Kangbai & Koroma, 2013;
William, 2010). Williams (2010) observed an improvement in cure rates among DOTS
patients due to program expansion, but the author did not consider failure rates and
default rates in their investigation. Kangbai and Koroma (2013) reported a high incidence
rate, high mortality rates, and a fluctuating default rate among patients undergoing DOTS
treatment; however, they failed to explain patient attributes that account for the observed
trends.
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Although the aforementioned studies have shed light on important findings on
trends and success rates of the DOTS program in the treatment and control of TB, I have
found no research on patient characteristics that influence treatment outcomes in Sierra
Leone. As a consequence, further research was warranted to examine the possible patient
characteristics associated with TB treatment outcomes in an effort to address the high
incidence and mortality rates despite decades of DOTS implementation in Sierra Leone
(Kangbai & Koroma, 2013; National Leprosy and Tuberculosis Program, 2010).
Purpose of the Study
The purpose of this quantitative study was to investigate patient characteristics
that affect the successful treatment of TB among TB patients under the DOTS in Sierra
Leone. TB treatment outcome is affected by a multitude of factors, such as availability of
TB drugs, compliance with the treatment regimen, early diagnosis, the age of the patient,
socioeconomic status, HIV prevalence, and stigma (Kangbai & Koroma, 2013). Research
on TB treatment outcomes in Sierra Leone is scant, even though there is growing
evidence that the fight against the disease remains an uphill battle. In this quantitative
study, I investigated the relationship between the age of patients, TB category, and
treatment completion. I also examined the extent to which HIV status and gender predict
the likelihood of completing TB treatment.
The main outcome of interest in this study was treatment completion. Participants
are classified as having completed their treatment if their record shows that they have
gone through with their treatment for greater than or equal to 168 days. The dependent
variable was binary, with a simple “YES” for treatment completed and “NO” for
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treatment not completed. The independent variables that were tested for treatment
completion were participant’s age, gender, HIV-status, and TB category. Participants’
education, marital status, and geographic location were the controlled covariates that
were adjusted for in this study.
Research Questions and Hypothesis
The following research questions (RQs) were addressed in this quantitative study:
RQ1: Is there an association between age and TB treatment completion among TB
patients in Sierra Leone when adjusting for education, marital status, and
geographic location?
H01: There is no association between age and TB treatment completion
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
H11: There is an association between age and TB treatment completion
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
RQ2: To what extent does gender predict the likelihood of treatment completion
among TB patients in Sierra Leone when adjusting for education, marital status,
and geographic location?
H02: There is no difference in the odds of TB treatment completion
between men and women among TB patients in Sierra Leone when
adjusting for education, marital status, and geographic location.
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H12: The odds of treatment completion are different for men and women
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
RQ3: Is there an association between TB-case category and TB treatment
completion among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location?
H03: There is no association between TB treatment completion and TBcase category among TB patients in Sierra Leone when adjusting for
education, marital status, and geographic location.
H13: There is an association between TB treatment completion and TBcase category among TB patients in Sierra Leone when adjusting for
education, marital status, and geographic location.
RQ4: To what extent does HIV status predict the odds of TB treatment
completion among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location?
H04: There is no difference in the odds of treatment completion between
HIV-positive patients and HIV-negative patients among TB patients in
Sierra Leone when adjusting for education, marital status, and geographic
location.
H14: The odds of treatment completion are different for HIV-positive
patients and HIV-negative patients among TB patients in Sierra Leone
when adjusting for education, marital status, and geographic location.
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Theoretical Background
The theoretical framework that guided this study was Andersen’s (1968)
behavioral model of health service utilization (Andersen, 1995). This model has been
widely used in several studies dealing with factors that affect health service use,
including those investigating difference health care systems as well as different diseases.
The purpose of the model is to demonstrate how a variety of factors influences health
service utilization. The model predicts that health service usage is determined by
predisposing factors, enabling factors, and the need for health service utilization (Li,
Matthews, Aranda, Patel, & Patel, 2015). Predisposing factors include demographic
factors such as age, gender, and race; social factors such education, occupation, and
social relationships (family status); and mental factors or health beliefs such as attitude,
values, and knowledge about health and health services (Li et al., 2015). Enabling factors
are conditions that enable service utilization (Li et al., 2015). They may include access to
insurance, family support, and organizational factors such as means of transportation,
travel time, and wait time for services. The need for health service usage can be described
as perceived need (an individual’s perception of his or her health), and actual need as
objectively assessed by a professional for medical care (Babitsch, Gohl, & von Lengerke,
2012). Therefore, Andersen’s model offers guidance on the characteristics that dictates
medical care usage.
Nature of the Study
I used a retrospective, longitudinal quantitative study to investigate patient
characteristics and how they affect TB treatment completion among patients enrolled in
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the DOTS program in Sierra Leone. In a retrospective study, the outcome of interest is
already known, and the researcher traces back to establish a relationship between the
outcome and possible risk factors (Frankfort-Nachmias & Nachmias, 2008). In this study,
the data were based on patients that already have TB and are registered in TB facilities
administering the DOTS program. I selected participants from four randomly-selected
DOTS centers representing each of the four political regions of Sierra Leone (the
Western Area and the Eastern, Northern, and Southern Provinces).I undertook a
retrospective analysis of secondary data that were extracted from follow-up treatment
records, hospital registers, and National Leprosy and Tuberculosis Control Program
archives on each patient. Information was extracted from all TB cases registered in each
of the four randomly selected centers between January 2013 and December 2015.
A retrospective design was appropriate for this type of study because it was costeffective and time-saving and does not expose subjects to harm due to intervention
effects. Retrospective study designs are also suitable for the analysis of multiple
outcomes, and more so in the investigation of rare diseases (Aschengrau & Seage III,
2014). I employed both binary and multiple logistic regressions to determine the
influence of my independent variables of age, gender, marital status, HIV status,
geographic location, and TB category on the dependent variable of treatment completion.
Definition of Key Terms
The following terms are defined as they apply to this study in order to clarify their
usage throughout this document. The definitions here might be difference from general
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usage. However, it is the intention that there is no ambiguity when it comes to their usage
in this document.
General Definitions
Directly-observed therapy short-course/directly-observed therapy (DOTS/DOT):
DOTS, or simply called, DOT, is a WHO-recommended method of anti-TB drug
administration in which patients receive their daily TB medications under the supervision
of a healthcare worker or sometimes an entrusted family member (WHO, 2016). The two
abbreviations are interchangeably used in this study.
Smear-negative pulmonary TB: This refers to a situation where two or more initial
sputum samples from a patient are negative for acid-fast bacteria, or where one initial
positive AFB sputum is found but radiographic abnormalities are consistent with active
TB disease determined by a clinician. The person doesn’t also respond to broad-spectrum
antibiotics in the absence of HIV (Demeke, Legesse, & Bati, 2013).
Smear-positive pulmonary TB: This refers to a situation where one or more initial
sputum of a patient are positive for acid-fast bacteria (AFB) or one initial positive AFB
sputum plus a radiographic indicative of an active TB disease determined by a clinician
(Demeke, Legesse, & Bati, 2013).
Tuberculosis (TB): TB of the lungs (pulmonary TB) or TB of other body organs,
such lymph nodes, abdomen, skin, joints, bones, meninges, pleura, and genitourinary
tract, otherwise known as EPTB (Endris et al., 2014).

18
Definition of Dependent Variable
Treatment completion: This is defined as patients who have completed at least
168 doses of their medication (6 months’ treatment) and their initial positive sputum
converted to negative sputum at the end of the treatment. It also includes those who do
not meet this conversion criterion but neither can they be described as having failed
treatment. They include patients with sputum-positive and sputum-negative pulmonary
TB as well as those with EPTB disease that has been described as free of the active TB
disease after treatment.
Definition of Independent Variables
Age: This is defined as the time between the day a person was born and time they
were diagnosed with TB expressed in years. In this study, the measurement of age was a
categorical variable.
Gender: This is a nominal variable that is defined as the being of male or female.
HIV status: This is defined as having been tested for HIV such that the patient’s
status is known (positive or negative; CITE). The variable is a nominal variable with two
measurement levels.
TB-case category: This refers to the patient category at the start of treatment. The
measurement is dichotomized into whether the case is new and nonnew, which includes
retreatment and relapse cases.
Definition of Covariates
Education: This is defined as an ordinal variable with four categories:
noneducation, some elementary, some high school, and some posthigh school education.
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Geographic location: This is defined as one of the four political divisions of the
country (Western Area and Northern, Eastern, and Southern Provinces) from where
patient data were collected and where patients are assumed to reside during the course of
treatment. The variable is measured at the nominal level of measurement.
Marital status: This is defined as being in a relationship at the time of diagnosis.
The variable is dichotomized into single and being married.
Assumptions
The conclusion of this study will remain valid based on the fact that the following
assumptions hold. It was assumed that the hospital registers and patient visit records from
the four regional government hospitals contained data that were representative of all TB
cases in the country within the specified period of time. It was also assumed that all cases
monitored by the centers were followed and the end points (deaths) recorded. The
premise of this assumption may be difficult to ascertain since most deaths are not
reported, making it difficult for health workers to ascertain endpoint or conclude loss-to
follow-up.
Scope and Delimitation
The main focus of this study was to look at the influence of patient characteristics,
such as gender, age, HIV status and TB category, on TB treatment outcome (completion).
There are few studies in the literature on Sierra Leone that have addressed this issue, even
though studies indicate that TB continues to increase (Kangbai & Koroma, 2013;
William, 2010). In this study, I included data only on TB patients registered under the
DOTS program at the four regional hospitals between the years 2013 to 2015. Hospital
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and patient records outside these facilities and years were included in the study. Since I
assumed that the characteristics of the patients in the selected hospitals generally
reflected those of the general population, the outcome of the study was generalizable to
include the entire TB patient population in Sierra Leone.
Limitations of the Study
In this study, I analyzed secondary data from hospital registers and patient records
that were recorded on each TB patient at the four selected regional hospital centers in
Sierra Leone. The study was therefore limited to those TB patients registered in those
DOTS centers to receive TB treatment. At the time of the study, the data capture and
storage system in Sierra Leone was still manual and recorded on hard paper copies
instead of electronically. There was a possibility of the occurrence of errors during data
collection. It was also possible that patient information may have been lost during
storage, especially in situations where patients have more than one patient card. In
addition, there was no way to match patient information from previous encounters, as is
easily done with electronic data recording and storage. These limitations may have led to
loss of vital information and may threaten the validity of the outcome, depending on the
magnitude of the loss.
There was also a potential threat to both internal and external validity with respect
to the secondary data on study participants that are collected and stored. One of the major
threats to validity in this study was the selection of the regional hospitals in question, as
well as the selection of samples within the study period in each of these hospitals. This
selection may have introduced selection bias, as not all hospital facilities are the same,
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nor are the patients who are served in those hospitals. Another threat to internal validity
was experimental mortality. Since TB treatment requires a long duration, at least 6
months, some patients may have found it difficult to continue treatment and may have
dropped out of the program. In Sierra Leone, where deaths are not always recorded, some
of these censored may be erroneously recorded as dead. For those that are able to
continue to pass a certain time threshold, mostly after 2 months, may be motivated to do
so and thereby improve their treatment outcome regardless of their characteristics. Some
patients may also be turned off by the personnel in the treatment center. Changes in such
personnel who act as an agent of instrumentation in outcome measurement may have
affected changes in the outcome as well.
I addressed the threat to validity in that the four chosen hospitals are the main
reference hospitals in each region for the treatment of TB. They receive the bulk of the
TB patients, and therefore, were representative of the entire TB population, as fewer
patients are treated outside the four facilities. Since only four DOTS centers were
selected for this study from the entire country, it was assumed that DOTS program in
each hospital, along with patient characteristics, were fairly similar regardless of the
location. I addressed sample selection bias by randomly selecting the representative
samples from records following simple random sampling technique. Furthermore, since
recording errors are random and not systematic, any effect introduced canceled each
other out.
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Significance of the Study
My findings in this study shed light on the efficacy of the DOTS program as
implemented to treat TB in Sierra Leone for decades. The findings fill a gap in the
literature by providing information on those patient characteristics that contribute to
successful TB treatment outcomes among patients enrolled in the DOTS program in
Sierra Leone. The study findings have significant implications for social change policy
and practice, being that even decades after the implementation of DOTS, no study has
been conducted to investigate patient characteristics among the treatment population that
contributes to patient treatment completion. An understanding of the relationship between
treatment completion and patient characteristics will help inform decisions, both for
policy makers and health professionals involved in the program, to concentrate resources
in areas where they may have the greatest impact on TB treatment and prevention.
Therefore, the outcome of this study will create positive social change by improving the
DOTS program’s efficacy. At the same time, the study findings may identify the
characteristics of those pockets of patient population who are at high risk of defaulting on
their treatment, thereby providing information that can lead to improved national
surveillance. Increased monitoring of such groups and providing special attention to
them, may improve compliance, and hence, reduce the TB burden in the population.
Summary and Transition
Sierra Leone is among the 30 countries with the highest burden of TB in the
world (WHO, 2015). Despite decades of antimicrobial TB treatment under the DOTS
program, the incidence of the disease still continues to increase (Kangbai & Koroma,
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2013). The government, in collaboration with development partners, has dramatically
increased the number of DOTS centers in the country (Kangbai & Koroma, 2013).
Despite all these efforts, the government failed to meet the 2015 Millennium
Development Goal for reducing the prevalence of TB to half of the 1990 level (WHO,
2016). This failure indicates that availability of DOTS centers alone is not sufficient in
reducing the incidence rate, but other factors such as patient characteristics should also be
taken into account. In order to better understand the problem, with this study I sought to
investigate some of those patient characteristics that may militate against treatment
completion, and hence, increase TB transmission and incidence rates. In Chapter 1, I
have presented a brief description of the study topic, outlined the problem statement, the
purpose of the study, the scope of the investigation, the research questions to be explored,
and possible limitations of the study. In the following chapter, I will provide a detailed
review of literature in terms of scope, variables of interest, and methodology employed in
the various studies.
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Chapter 2: Literature Review
Introduction
TB has made a resurgence after many years of decline. This resurgence can be
attributed to changes in the social structure in cities, the increase in the prevalence of
HIV/AIDS, the cost of TB treatment, and the failure to improve public health programs in
most cities (Driver et al., 2005). Anuwatnonthakate et al. (2008) opined that the major
barrier to the global control of TB is the noncompliance of patients with treatment and
the long duration of the treatment course. The effective treatment of TB requires 6 to 9
months of chemotherapy with antibiotics (Munro et al., 2007). Nonadherence to
treatment increases the risk for development of drug-resistant TB, thereby reducing the
chances of cure (Maartens & Wilkinson, 2007). Nonadherence may also lead to
prolonged infection, development of drug resistance, and increased morbidity and
mortality (Getahun, Ameni, Medhin, & Biadgilign, 2013).
In this chapter, I will provide a comprehensive review of the literature that is
currently available regarding the present research study - patient characteristics and
treatment outcomes among TB patients in Sierra Leone. In order to provide such a basis
for the purpose of the study, I will provide a detailed description of the literature search
strategy that was used in the review. This was necessary to show that the information
included was systematically evaluated for the purpose of providing the most extensive
data available. Keywords and terminology were included in order to allow for the
replication of this search strategy to further provide validity to the results. In the chapter,
I will review selected literature to define and justify the use of the Andersen’s behavioral
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model of health services utilization. I found this to be relevant to provide the reader with
a better basis for understanding the process of the present research as this involves the
factors associated with treatment compliance (Li et al., 2015).
The chapter will contain a brief review of the literature associated with the factors
influencing the utilization of health care services in general. This review will provide the
reader with the most recent findings in the field of research associated with the utilization
and compliance of health care treatments. This section will be followed by a review of
the literature on the implementation of DOTS in selected African countries including
Sierra Leone. This will lead to a general description of the DOT protocol, which will
become more directly related to the study as I will present data regarding the studies that
relate to research variables (the independent variables of age, gender, HIV status, and
TB-case category and the dependent variable of treatment completion).
Finally, as the literature review comes to a close, I will provide support for the
research method and design by reviewing previous studies that have utilized similar
methods to collect data in health care research. A summary of findings throughout the
literature review will then be provided with the most relevant information being
highlighted for recollection as the present research continues. This will allow for a
reliable transition into Chapter 3 where I will present the methodology of this study.
Literature Search Strategy
For the purpose of this literature review, I used a selection of peer-reviewed
journal articles and government-affiliated documents. These documents were accessed
electronically through the Walden University Library and Johns Hopkins Medical
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Institute websites. The articles were retrieved from academic databases, along with
government, and other institutional websites. I searched the ProQuest, PubMed, Medline,
Thoreau, Science Direct, Google Scholar, World Health Organization, Center for Disease
Control and Prevention, and Ministry of Health and Sanitation of Sierra Leone databases
and search engines. Each of these databases and search engines connects to both
government and peer-reviewed documents in a way that allows for the use of key terms
and arrangement by relevance to the keywords and the date of publication. I omitted
duplicate publications from the search, allowing for a more comprehensive assessment of
the available literature.
In order to retrieve the most relevant results for this literature review, I selected
keywords that would allow for a more direct line of results, and therefore, minimize the
necessity to review literature that would not add to this study. These keywords consisted
of the following terms: tuberculosis, tuberculosis in Sierra Leone, directly observed
therapy, treatment compliance, self-administered therapy, Tuberculosis and Treatment
outcome, National Leprosy and Tuberculosis Program, HIV and tuberculosis,
compliance and demographics, and Andersen’s behavioral model of health services
utilization. The words are serach individually and in word combination.
Inclusion Criteria
I subjected the literature sources selected for review to the following inclusion
criteria:
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•

Literature source was recent having been published within the time period of
2010–2016, with the exception of some very few articles relevant to this
study.

•

Literature source was peer reviewed or provided by a government source.

•

Literature source was written in English.

•

Literature source was found to be relevant to the overall research questions of
this study.

Exclusion Criteria
In order to compose a literature review with the most accurate and relevant
information, the literature sources I reviewed for this study were subjected to the
following exclusion criteria:
•

Literature source did not meet the inclusion criteria.

•

Literature source was repetitive having cited more than five other sources
being utilized in the review.

•

Sample size of the study did not represent the target population.

•

Literature did not provide ample documentation to support the validity of the
study.
Conceptual Framework

I chose Andersen’s behavioral model of health service utilization as the
theoretical framework to guide this study (Andersen, 1995). This model has been widely
used in several studies dealing with factors that affect health service use. It has been used
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in studies investigating difference health care systems as well as different diseases. The
purpose of the model is to demonstrate how a variety of factors influences health service
utilization. The model predicts that health service usage is determined by predisposing
factors, enabling factors, and the need for health service utilization (Li et al., 2015). In
order to provide the most comprehensive understanding of the selection of this theoretical
framework, I found it necessary to select literature that both defined the components of
the framework and that which has used this theoretical framework in an effort to show
the application of these components in a practical manner. Therefore, this section will be
divided between those two foci, respectively.
According to Anthony et al. (2007), the expanded version of the behavioral model
of health service utilization consists of four conceptual categories that allow for a better
understanding of the likelihood of patients to be compliant with the treatment protocol
that is selected for their illness: traditional predisposing factors, enabling factors, need
factors, and vulnerable predisposing factors. Anthony et al. explained that the first of
these, the traditional predisposing factors, involve demographic variables, while the
second category enabling factors are more related to socioeconomic variables such as
medical insurance availability. The third category, need factors, are based on the
necessity for other medical care such as a terminal illness or disability, and the final
category, vulnerable predisposing factors, are categorized by the psychosocial issues such
as support and behavioral variables (Anthony et al., 2007). In their article, Anthony et al.
provided a basis for comprehending the substructure of the behavioral model of health
service utilization.
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Bergman, Haley, and Small (2011) further explained that Anderson’s behavioral
model of health service utilization can be applied to all areas of health care services,
including mental health and bereavement services, as the factors associated with
utilization are applicable determinants in these areas in as much as they are applicable to
disease maintenance treatment protocols. Bergman, Haley, and Small provided additional
defining characteristics of the term predisposing as being characteristics which
present prior to the onset of need, deter or predispose individuals from using
health care services. Examples include demographic characteristics (e.g., age),
aspects of social structure (e.g., race), and health beliefs (e.g., perceptions and
knowledge of the disease and medical care) (p. 532).
Presenting a study that was conducted longitudinally with multiple sites for sampling,
Bergman, Haley, and Small found that the geographical differences were not as highly
associated with the utilization of bereavement services so much as were the belief sets,
found to be related to religiosity, and the presence of other mental health conditions. This
information was noted to be helpful to mental health professionals in assessing the needs
of the mourners and to structuring bereavement services in a manner that would be
acceptable based on these predispositions (Bergman, Haley, & Small, 2011).
In a recent study, Li et al. (2015) also used Anderson’s behavioral model of health
service utilization to examine the association between negative experiences in the health
care setting that influence the utilization of health care services among sexual minority
African American women. The model helped them in understanding how predisposing

30
(young age), enabling, and need factors predicted negative experience. They also found
that patient and health care factors were associated with low health service utilization.
Kim, Jang, Chiriboga, Ma, and Schonfeld (2010) also used Anderson’s behavioral
model of health service utilization in a recent study regarding the utilization of mental
health services in the elder Latino and Asian immigrants. As the study necessitated, the
framework was adapted to include the components of (a) predisposing factors, (b)
enabling factors, (c) need factors, and (d) mental health service use outcome. However,
the primary guidance of the study followed the framework as presented by Anderson and
maintained that the factors were substantially valid for the purpose of obtaining adequate
data regarding the utilization of these health care services. Kim et al. explained that the
use of this framework allowed them to use Anderson’s findings as a baseline for adding
to the knowledge base to be applicable to all health care services. Kim et al. found that
for elder immigrants, the need factors were more often associated with the decision to not
utilize mental health services and explained that this data is in support of culturally
specific mental health services, noting possible implications for other areas of health care
services as well (such as the utilization of DOTS program in the treatment of TB).
In this section, I provided the basis for the use of the behavioral model of health
service utilization in multiple areas of health care service studies. It has been shown that
predisposing factors can be viewed as demographic variables such as age, gender, race;
social factors such as education, occupation, and social relationship (family status); and
mental variables or health beliefs such as attitude, values, and knowledge about health
and health service (Bergman, Haley, and Small (2011) ). Enabling factors are conditions
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that enable service utilization. They may include access to insurance, family support, and
organizational variables such as means of transportation, travel time, and wait time for
services. The need for health service usage can either be described as perceived need as
an individual’s perception of his health, and actual need as objectively assessed by a
professional for medical care (Babitsch et al., 2012). Therefore, Andersen’s model offers
guidance on the characteristics that dictates medical care usage such as those of the
DOTS program in the treatment of TB.
Factors That Influence the Utilization of Health Care Services
I devoted the previous section of the literature review to the conceptual
framework to provide the reader with an introduction that ties the study to a grounded
theoretical framework. In this section, I will discuss the general factors that are associated
with or contribute to the use or neglect of health care services by patients in all areas of
medical services. I feel that it was necessary to provide a more detailed analysis of the
literature available that better defines these factors.
In an attempt to investigate factors that affect health services utilization,
Ragnarsson et al. (2011) explored the factors or barriers that hinder sexual behavioral
change among patients receiving antiretroviral treatment. The authors identified gender
as being a factor in noncompliance with a special emphasis on the male gender.
Ragnarsson et al. suggested that men suffer from more chronic illnesses than do their
female counterparts yet have developed beliefs and behaviors that prevent them from
either utilizing the health care services and/or adhering to the recommended treatment
protocol. Ragnarsson et al. indicated that this correlation is two-fold as the beliefs and
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behaviors place the males at a higher risk for chronic illnesses while the noncompliance
prevents them from receiving adequate symptom control or a cure for the illnesses that
they suffer from (whether due to the beliefs or behaviors or stemming from other external
factors). Notably, Ragnarsson et al. explained that the ethnicity, economic status,
educational level, sexual orientation, and familial and cultural beliefs regarding
masculinity are also well established as being factors in the gender differences in
compliance to medical treatment protocol with particular emphasis on the risks associated
with HIV.
De Joode, van Boxtel, Verhey, and van Heugten (2012) continued the discussion
regarding the societal and cultural beliefs as being a factor in determining the compliance
to health care treatment protocols and the utilization of health care services that was
discussed by Ragnarsson et al. (2011) as the researchers noted that individual behaviors,
no matter how independently processed, are inevitably linked to the familial and cultural
teachings that have been communicated from infancy. For instance, deJoode et al.stated
that the use of technology, for some generations, has been considered to be absent from
the natural progression of the human condition and therefore find that the use of
technology in the medical field is also against the laws of nature. De Joode et al.
explained that the perception of technology in generations or regions that have not had
excessive access to technology is generally related to the fear and predisposition to avoid
the use of health care services that may require or indicate the use of technology as a
product of being afraid of the unknown.
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Additionally, Ackerman, Ademi, Osborne, and Liew (2013) discussed the factors
related to socioeconomic status that impact the utilization of and compliance with health
care services. Specifically, Ackerman et al. addressed those among the lowest
socioeconomic classes who live not only in poverty but without adequate housing who
are in need of mental health services. Because of the vulnerability of this class of citizens,
there is an increased risk associated with homelessness and other concerns such as mental
health, substance use, residential history, competing needs, and victimization.
Independently, all of these additional concerns has been discussed as factors associated
with noncompliance. However, when combined, the population of homeless individuals
is found to be among the highest in need but lowest in utilization. Ackerman et al.
attributed this disparity to other factors including the accessibility of insurance, the ability
to have transportation to the health care facilities, and the demands of meeting their basic
needs over the belief that the health care compliance is necessary to their wellbeing.
Johnson, Moser, and Garwood (2013) agreed with Ackerman et al. (2013)
regarding the combination of multiple factors as being an indicator for noncompliance,
adding that the health care literature is more accessible to those in the higher
socioeconomic statuses than to those who are impoverished or homeless. Johnson et al.
noted this disparity especially in regards to mental health information as many of the
available sources of literature are found at the offices of family physicians which are not
often frequented by the homeless or those in poverty due to the limited access to
transportation and medical insurance. Reeves et al. (2015) explained that this leads to an
increase in the occurrences of undocumented cases of tuberculosis and serves to eliminate
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the potential for medical treatment interventions and health care utilization. Other forms
of literature that may help a patient to recognize their symptoms and prepare them with
questions regarding these symptoms and treatment options can be found in mass media,
access to which is also limited for those with lower socioeconomic status. Johnson et al.
warned that this limited information leads to misconceptions and often serves to confirm
the belief sets that have prevented the utilization of health care services from the onset of
these symptoms.
Ameigh, Semler, Lebkuecher, and Scanlan (2015) further explained these factors,
along with numerous others, that show the average noncompliance rate to be
approximately one quarter. The research found that noncompliance was more often
viewed in the maintenance of medication regimens and the continuation of ongoing visits
to the physician in regards to illnesses such as diabetes and sleep disorders. Ameigh et al.
noted that demographic differences were not as notable as were the types of disorders for
which the patients required medical treatment, and that the more severe the illness, the
higher the research found the compliance to be. Nonadherence, especially in areas where
resources are limited, and the medications are difficult to obtain, is viewed as being
wasteful and socially irresponsible as the increased burden on the society can be
witnessed in the health depletion of the noncompliant patient as well as in those who are
not able to access medication due to the noncompliant patients having been given the
necessary resources (Weibing et al., 2015).
Vijay et al. (2010) explained that the predictive factors associated with
noncompliance can aid in preventing drug resistance, relapse, death, and treatment
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failure. In order to ensure adequate utilization of available resources and that the social
burden of noncompliance does not extend beyond the realm of acceptability, Vijay et al.
recommended continued research as to the factors associated with noncompliance. They
also recommended continued ability to evolve and adapt the programs that are intended
to encourage compliance, ensure proper use of the researchers, and improve the overall
outcomes of treatment for most patients.
Within this section of the present research I have provided the reader with a more
in-depth description of the types of factors that are involved in the decision of the patient
to either avoid medical services or to not adhere to the medical treatment protocol
recommended by health care professionals. I have also attempted in this section to
provide some examples that lend to the understanding of why individuals who are facing
significant health issues and/or fatality due to their noncompliance continue to exhibit
this behavior. Noncompliance to medical treatment protocol by individual patient can
result in the limitation of resources for an entire population. Next, then, this literature
review examines health care utilization by more specific populations.
Literature Related to Directly Observed Therapy Short-Course (DOTS) and
Variables of Interest
In this section I focused on directly observed therapy short-course as it applies to
the utilization of and compliance with health care services. It will also focus on literature
that is related to both independent and dependent variables of interest in this research.
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Directly Observed Therapy Short-Course (DOTS)
DOTS an international treatment protocol with a strategy comprised of five
components: political commitment by national governments, improved laboratory
facilities with quality sputum-smear microscopy capabilities, regular supply of anti-TB
drugs, direct observation of each patient swallowing their medications under a health care
worker, and standardized recording and reporting system for patient and program success
(Pasipanodya & Gumbo, 2013). Duwell et al. (2013) noted that directly observed therapy
differs from the traditional use of self-administered therapies in that the patient is given
the medication, or observed in its administration, to ensure that the patients receive the
proper dosage at the proper intervals with the compliance concerns being restricted to the
utilization of this service whereas the self-administered therapies rely on the ability of the
patient to administer the medication and the willingness of the patient to adhere to the
schedule without the accountability that is entailed in the directly observed therapies. The
success of DOTS in increasing compliance, reducing the number of new cases, and
preventing the development of drug-resistant TB has been widely publicized (Hsien-Ho,
et al., 2015; Obasanjo, Shields, Coggin, Chaisson, & Glass, 2012). Duwell et al. found
that the outcomes for patients were significantly improved by utilizing directly observed
therapy when compared to the use of self-administered therapies.
Khogali et al. (2014) discussed the use of self-administered therapies for the
purpose of treating tuberculosis in rural Ethiopia. The researchers explained that the
participants were given adherence training and communication in order to promote
compliance with medical treatment protocol. Utilizing patient follow-up and
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communication techniques, Khogali et al. referred to this protocol as a modified direct
observation therapy with an adaptation for a self-administered therapy. This was found to
be more effective in rural areas whereas access to a more sustained direct observation
therapy facility was limited than was the more rigid direct observation therapy as the
patients were not limited to their transportation access but were granted the added support
that would not be present in a traditional self-administered therapy. This was significantly
a beneficial study as many of the patients in Ethiopia are in rural areas, and the
compliance in these regions has been reported as being less than adequate for treating
tuberculosis (Khogali et al., 2014).
Bruce et al. (2012) claimed that the directly observed therapies are superior to the
self-administered therapies and also added that the former keeps many of the factors that
are associated with noncompliance and avoidance of medical services from surfacing in a
manner that prevents the best possible outcome for the patient. In fact, Bruce et al.found
that the experience level of the individual in relation to how to administer the medication,
the socioeconomic status of the individual patient, and the demographic background of
the patients did not significantly influence compliance to TB treatment when utilizing the
directly observed therapy method of administering necessary medication. This shows
that, when patients are given the scenario to be held accountable for their compliance
with the medication treatment protocol, they can actually move beyond the barriers to
their health and the disparities between races, genders, and socioeconomic statuses can be
dissolved in a clinical setting (Gärden et al., 2014).
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Beckman (2013) added that, in regard to the social responsibility of
noncompliance, there is a significant concern about the costs associated with the directly
observed therapy methods. Using a study related to mental health services, Beckman
claimed that self-administered therapies are more cost effective when considering the
personnel required to administer the treatments, the occurrences of noncompliance, and
the rise in health care insurance costs that are then dispersed into the general population
as the directly observed therapies are much more expensive than the self-administered
therapies (Lunte, Thierry, & Joel, 2015). However, the concern of the noncompliance
risks associated with the self-administered therapies must also be evaluated in the context
of valuable resources and the ability of those who will be compliant also to have access to
the necessary medications (Fitzpatrick et al., 2015).
Gender, Age, TB Category, HIV Status and TB Treatment completion
The successful completion of tuberculosis treatment is not only dependent on the
implementation of a TB treatment program, but also on multiple factors. These factors
include patient age, time of presentation for diagnosis, prevalence of HIV, socioeconomic
status, poor compliance, access to health care services, substance abuse and drug
resistance (Demeke et al., 2013; Gelmanova et al., 2007; MOHS, 2010; and Williams,
2010).
Demeke et al. (2013) undertook a study to assess the trend of TB and treatment
outcomes among patients that attended the Gambella Regional Hospital in Ethiopia. The
authors found that the treatment success rate (TSR) was significantly associated with
gender, age, and year of enrollment of the patient in the program. The study demonstrated
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a higher treatment success rate among females relative to males. Higher default and death
rates were observed among males than females. The treatment success rate was inversely
proportional to age. The age 014 years had the highest TSR (72%), and > 64 years had
the lower TSR (44%). However, they did not establish any statistically significant
association between treatment success rate and forms of TB, patient category, and smear
result. The death rate among TB patients undergoing treatment was significantly
associated with age and year of enrollment in the program.
A similar study by Syed (2014) attributed a significant percentage of TB cases to
noncompliance, and multidrug resistance as the patients do not continue with the regimen
through the self-administered therapies and therefore the disease becomes resistant and
additional protocols are required in order to gain the same level of success as would have
been achieved should the patient had been compliant or been involved in a directly
observed therapy. The study concluded among TB patients, that age below 60 years,
illiteracy, rural residence, and extrapulmonary TB negatively impacted the treatment
success rate; and was found to be significantly associated with treatment failure among
TB patients.
Getahun, Ameni, Medhin, and Biadgilign (2013) investigated treatment outcomes
among 6450 TB patients in Ethiopia. Among these, 3147 were males, and 3433 were
females. The study shows that 64.6% completed treatment, 18.1% were cured, 3.7% died,
5.1% defaulted, 0.4% failed treatment, and 8.2% were transferred out to other centers.
The overall treatment success rate was observed to be 82.7%. Getahun et al. did not find
any statistically significant relationship between gender and treatment success rate.
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However, they did conclude that year of enrollment and treatment center were
significantly associated with treatment success rate.
The authors explained that tuberculosis is more isolated in the lesser developed
areas of Ethiopia that have yet to reach the level of medical compliance of their more
developed counterparts around the world. However, the historical cohort study that is
presented by Getahun et al. (2013) suggested that this trend may be alleviated through the
continued adherence of directly observed therapies so long as these remain available, and
the information regarding these practices is sufficiently delivered to all individuals across
the region.
Gadoev et al. (2015) reported a similar treatment success rate of 83% in their
study to examining factors associated with unfavorable TB treatment outcomes of
patients enrolled in the directly observed therapies in Uzbekistan. However, the authors
noted that there was significant disparity among the more vulnerable populations and that
there is a need to improve TB services for such groups. The findings showed that death
and loss to follow-up among TB patients were associated with being older male (> 55
years), previously treated for TB, living in urban settings, experiencing joblessness,
having sputum positive pulmonary TB (SPPTB), and being HIV positive. Loss to
follow-up and death were not significantly associated with adolescence or having
EPTBdisease. Treatment failure was also associated with urban residency, adolescence,
joblessness, previous history of TB, HIV-positive status, and having positive sputum
smear. This further elaborates on the factors established in the conceptual framework
section of the present literature review as the combination of various factors was highly
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indicated as being an increased predictor of noncompliance and unsuccessful rates of
treatment (Blank, 2012).
The majority of the studies above established a significant association between
treatment outcome and gender, age, residence, type of TB and HIV status (Demeke et al.,
2013; Gadoeve et al., 2015; and Syed, 2014). However, in a retrospective study to assess
treatment outcomes and associated risk factors, Endoris et al. (2014) did not find any
significant association between sex, age, residence, HIV status, type of TB and successful
TB treatment. Among the 417 study subjects, 94.8% had a successful treatment out
(75.5% completed their treatment, and 19.3% were cured). The remaining 5.2% had
unfavorable treatment outcomes, with a 3.4% death rate, a 1.2% failure rate, and 0.5%
default rate.
The incidence rate of TB infection has been exacerbated by the advent and spread
of HIV. Jemal et al. (2015) explained that coinfection with HIV has created a scenario
that further hinders the success of treatment protocols for these patients. The study
revealed that 20% of the 2,970 patients undergoing TB treatment were co-infected with
HIV. It also shows that coinfection with HIV and being male were significantly
associated with unsuccessful TB treatment. This coinfection together with the multidrug
resistance have been noted to decrease the success rate of the treatment protocols and
increased the occurrences of deaths related to the onset of tuberculosis.
Gao, Zheng, and Flu (2013) conducted a similar study to determine the worldwide
prevalence of HIV/TB coinfection. Gao et al. carried out a systematic and meta-analysis
of existing literature to determine the prevalence of TB and HIV coinfection worldwide.
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They identified 47 studies covering HIV/TB coinfection with a total sample size of
272,466. The results of the meta-analysis showed an estimated TB/HIV coinfection
between the ranges of 2.93% to 72.34%. There was substantial heterogeneity in the
prevalence of TB/HIV co-infection across regions. The prevalence of TB/HIV
coinfection was 14.84%, 17.21%, 20.11%, 25.03%, 31.25%, in the U. S., Asian countries,
European countries, Latin-American countries, and African countries respectively. The
prevalence of TB/HIV coinfection was higher in studies in which TB diagnosis was made
by chest radiography, and HIV was diagnosed by blood analysis than studies in which
diagnosis was made by other methods. Coinfection of TB/HIV was also higher in
countries with high prevalence of HIV in the general population than those with lower
HIV prevalence in the general population.
Literature Related to Methods and Design
As this researcher has stated, the present research utilized a retrospective
quantitative study to investigate patient characteristics and how it affects TB treatment
outcomes among patients enrolled in the DOTS program in Sierra Leone; therefore, it is
necessary to provide evidence supporting the use of this methodology in the present
study. In a retrospective study, the outcome of interest is already known. The researcher
traces back to establish a relationship between the outcome and possible risk factors
(Frankfort-Nachmias & Nachmias, 2008). In this study, the data were based on patients
who already had TB and are registered in TB facilities administering DOTS program.
Participants were selected from four randomly selected DOTS centers representing each
of the four political regions of Sierra Leone (Western Area and Eastern, Northern, and
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Southern Provinces). Therefore, in this section I provided information supporting this
methodology and allow for a detailed understanding of the components involved.
The qualifier “retrospective” is assigned to the present study because of its use of
historical documents. El-Masri (2014) explained that the documents that are utilized for a
retrospective design must be validated and substantially supported by external evidence
in order to provide validity to the findings of the study. Garrison, Anderson, and Archer
(2010) go on to state that retrospective qualitative research studies have become more
prominent in the age of modern technology, where various historical documents can be
located through a search engine and the available supporting literature has become
increasing simplistic to locate. However, Garrison et al. also warned the researchers to
validate all information, as it is also much more simplistic for fraudulent accounts to be
integrated with legitimate sources of literature.
In regards to the quantitative approach to data collection and evaluation, Quick
and Hall (2015) noted that this approach prevents ambiguity in the presentation of the
findings, diminishes the potential for biased results, and allows for the statistical analysis
of the data to be conducted, evaluated, and presented with visual aids that allow for a
rapid assessment of the findings. Quick and Hall noted that in a retrospective study, it is
important to be able to provide such statistical data in order to show the relevance of the
historical documents as they pertain to the present state of the research and additional
values of variables that are being assessed alongside these documents. Bannon (2015)
added that the quantitative approach allows for the definition of missing data and the
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presentation of the existing data in relation to this definition. Table 1 below is a summary
of cross-sectional studies included in this review.
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Table 1
Evidence Table
Author(s)
Sunday, et al.
(2014).

Method/design
N (sample size)
Retrospective
N = 965

Measures
patient’s age, sex,
address,
tuberculosis
type, and
treatment
outcome

Statistical
method
Descriptive
statistics, bi
and
multivariate
Logistic
regression,
Chi-square

Syed, M. A.
(2014)

Prospective
observational study
N = 609

Age, TB category,
location,
education,
treatment
completion,
cured, default,
relapse, and
transferred.

Descriptive
statistics , Chi
square

Hamusse, et
al. (2014)

Retrospective
quantitative study
N = 14,221

Descriptive
statistics, bi
and
multivariate
Logistic
regression,
Chi-square

Getahun, et
al. (2013).

Retrospective
quantitative cohort
study
N = 6450

IVs: Area of
residence, age,
sex, HIV status,
TB patient
category,
treatment regimen
DV: Treatment
success
IVs: Age, sex,
location of center,
type of TB, type
of treatment, year
of enrollment.
DVs: treatment
outcome

Binomial
logistic
regression

Findings
965 patients seen, 304
(33.3%) were cured,
477 (52.2%) had completed
treatment given an overall
treatment
success of 85.5%, 87 (9.52%)
died, and 36 (3.94%) were
transferred out while 1
(0.01%) failed treatment.
Location and treatment
category were significantly
associated with favorable
treatment outcome
76.2% were cured, 59%
completed treatment among
smear negatives, and 36%) in
extra-pulmonary case.
24.3% defaulted, 2.6%
relapsed, 2.1% transferred
out, and 1.8% died among
hospitalize patients. Age <60
years, extra-pulmonary TB (p
= 0.0003), rural residents (p =
0.0000), and illiteracy (p =
0.02) were significantly
associated with failure of
treatment among TB patients.
Expansion of DOT increase
treatment success rate,
decrease death and default
rates, Aged 25-49, and ≥50
years, re-treatment cases, and
TB/HIV co-infection were
associated with unsuccessful
treatment outcomes
18.1% were cured, 64.6%
completed treatment, 3.7%
died during follow-up, 5.1%
were reported as defaulters,
0.4 failure and 8.2% were
transferred out to another
health institution. Treatment
center and year of enrollment
were significantly associated
with treatment success.

(Table continues)
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Author(s)
Vijay, et al.
(2010)

Method/design
N (sample size)
Case-control
N = 1374 (687
cases and 687
controls)

Measures

Demeke, et
al. (2013)

Retrospective study
N = 2303

IV: sex, age, year
of enrollment,
forms of TB,
patient category,
smear result
DVs: treatment
success rate
(TSR), death and
default rates

Chi-square,
univariate and
multivariate
logistics
regression

Endris, et al.
(2014)

Five-year
retrospective
cohort study
N = 417

IVs: sex, age,
residence, type of
TB, HIV status
DVs: successful
treatment, death,
and default rates

Bivariate and
multivariate
logistic
regression

Kurt, et
al.(2012)

Retrospective study
N = 1,776

IVs: sex, urban vs
rural,
DV: TB incidence
rate

Chi-Square
Linear-byLinear
Association
analyses.
Mantel
Haenszel Test

IVs: Alcoholism,
illiteracy,
Knowledge about
TB, commitment,
patient-provider
interaction,
support
DV: default

Statistical
method
Univariate and
multivariate
logistic
regression

Findings
Alcoholism, illiteracy,
having other commitments
during treatment, inadequate
knowledge of TB, poor
patient-provider interaction,
lack of support from health
staff, having
instances of missed doses,
side effects to anti-TB drugs,
and dissatisfaction with
services provided were
independently associated with
default
Gender, age and year of
enrollment of TB patients
were significantly associated
with TSR (p<0.05). However,
forms of TB, patient category,
and smear result were not
significantly associated with
TSR (p>0.05). Age and year
of treatment of TB patients
were significantly associated
(p<0.05) with death rate. Year
of enrollment was
significantly associated with
defaulted TB patients
(p<0.001)
379 (94.8%) patients had
successful treatment outcome
(302 complete treatment and
77 cured). The overall death
was 3.4%, default rate 0.5%,
and failure rate 1.2%. No
significant association
between successful TB
treatment outcome and sex,
age, residence, type of TB,
HIV status, were observed
New case TB rate increased
significantly with age every
year; there was a positive
correlation
between age and TB rate in
all years
TB development risk was
estimated to be the same in
urban and rural areas

(table continues)
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Author(s)
Gadoev et al.
(2015)

Method/design
N (sample size)
Retrospective study
N = 107,380

Jemal et al.,
2015

Retrospective study
N = 2970

Tolosie, &
Sharma,
(2014)

Retrospective
N – 826

Kangbai, &
Koroma,
(2013)
Williams,
(2010)

Retrospective
N = 2,958
Retrospective
N = not indicated

Measures
IVs: sociodemographic and
clinical factors.
DVs: lost-tofollow-ups, deaths
and treatment
failures

IVs: Sex, age,
HIV status,
DVs: death,
successful
treatment, default
and treatment
failure
IVs: age, body
weight at
initiation of
treatment, TB
patient category,
and HIV status
DVs: treatment
survival
Treatment success
and incidence
rates
IV: directly
observed
treatment shortcourse (DOTS)
DV: notification
and treatment cure
rates

Statistical
method
Univariate and
multivariate
logistic
regression

Bivariate and
multivariate
logistics
regression

Kaplan-Meier
plot, Logrank
test, univariate
and
multivariate
Cox
proportional
hazards tests
Descriptive
statistics
Descriptive
statistics

Findings
Age >55 years, HIV-positive,
sputum smear positive,
previously treated, jobless
and location were associated
with death
Being male, previously
treated, jobless, living in an
urban area, and living in
certain provinces were
associated with lost-tofollow-up
Having smear positive PTB,
being an adolescent, being
urban population, being HIVpositive, previously treated,
jobless and residing in
particular provinces were
associated with treatment
failure
Low treatment success rate
(TSR) of TB patients and a
declining trend of TSR
Co-infection with HIV and
being male correlated with
poor treatment outcomes
Age, TB patient category,
HIV, and age by HIV
interaction were significant
risk factors associated with
death status in TB patients

Incidence and treatment
success rates increased
Weak correlation between
treatment cure rate and DOTS
expansion
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Williams (2010) investigated the impact of DOTS on the TB treatment cure rate
in the postconflict period of 2002 to 2005. Data were retrospectively collected from
district TB registers and the annual TB reports for 2002 to 2005. The registers contained
summary data on TB cases compiled from treatment cards, and laboratory registers. The
collected data contain demographic information such as age, and gender, as well as
treatment outcome such as cured, completed treatment, defaulted, failed, and died.
However, the authors considered only cure rate as relevant in assessing program success.
The results show that there was no significant trend observed for infectious TB
incidence during the program implementation period between 2002 through 2005. The
lowest number of infectious TB cases was reported in 2003. There was a decline in the
number of reported cases during the third quarter of each month, which corresponded to
the peak of the rainy season. The expansion of the DOTS coverage improved DOTS
coverage and the treatment cure rate. However, the association between treatments cure
rate and DOTS coverage was weak.
A retrospective study was undertaken by Kangbai and Koroma (2013) to examine
the annual pulmonary tuberculosis (PTB) incidence rates in Sierra Leone between 1992
and 2010. A total of 2,958 patients, mostly adults between the ages of 15 to 65 years old,
were diagnosed and treated across various DOTS centers in the country. There were
1,881 males and 1,077 females. All patients were sputum positive for pulmonary TB and
enrolled for PTB treatment in all 13 regional Germany Leprosy Relief Association’s
(GLRA) diagnostic and treatment centers in Sierra Leone.
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The results of the study revealed that the incidence of PTB increased significantly
from 233 per 1,000,000 populations in 1992 to 682 per 1,000,000 populations in 2010.
Meanwhile, the treatment success rate rose concomitantly with incidence rate from 75%
in 1994 to 86% in 2010. The mortality rate declined slightly from 27% in 1992 to 21.8%
in 2010.
It is evident from the studies by Williams (2010) and Kangbai and Koroma (2013)
that the incidence rate of TB continuous to increase despite decades after the
implementation of the DOTS program. However, the studies are descriptive in nature
without any inferential statistics to evaluate the significance of the findings. Therefore,
the results cannot be extrapolated to include the general population. These articles are
relevant to my study, as they provide its epidemiological basis. It is evident that patient
compliance to treatment and those factors that contribute to treatment success or failure
were not investigated in either study. The aim of my study is to contribute to the gap in
the literature and provide sound scientific evidence for patient compliance to treatment as
contributing to treatment success rates.
Tolosie and Sharma (2014) conducted a retrospective study to investigate the
factors that affect the survival of patients enrolled in a DOTS TB control program. Data
were obtained from medical records of 826 patients. Among the total participants, 105
died (12.71%), and 712 were censored (87.29%). The authors used Kaplan-Meier (KM)
plots, logrank tests, and Wilcoxon tests to assess the survival patterns of patients with
respect to age, gender, body weight at the start of treatment, TB patient category, type of
TB, and HIV status. The KM plots show that there were differences in survival curves
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with respect to age category, initial weight at treatment, TB patient category, and HIV
status. However, gender, smear result, and type of TB did not show significant
differences in their survival patterns. This was confirmed by the logrank and Wilcoxon
tests to test the level of significance of the observed differences in survival patterns. The
tests confirmed that there were significant differences in survival experience among
patients in different age categories, body weight at initiation of treatment, TB patient
category and HIV status. However, no significant differences were observed with respect
to gender, smear result, and type of TB. Further analysis using the Cox proportional
hazards regression indicated that age, TB patient category, HIV status, and interactive
effect of age and HIV were significant factors associated with death among TB patients.
However, initial body weight at the start of treatment, smear result, and type of TB did
not significantly impact patient survival undergoing TB treatment.
Valadas et al. (2013) carried out a retrospective study to investigate TB/HIV or
malaria co-infection for patients admitted during 2007 at a large hospital in Luanda,
Angola. Data were collected on patient demographics, HIV status, and malaria diagnosis,
TB treatment method, and mortality data. A total of 4,666 patient’s data were analyzed
from hospital records. There were 1,906 (40.8%) patients diagnosed with TB, mostly
adults (> 14 years); among which 1,111 (58.3%) were male. The number of new cases
was 441 (54.4%), 220 (27.2%) were relapsed cases, 29 (3.6%) were a failure, and 120
(14.8%) were considered reappeared. About 604 (99.7%) out of 606 children (< 14 years)
were diagnosed with TB. A total of 712 TB patients (37.4%) were diagnosed with HIV,
and 714 of 1,906 TB patients (37.5%) were diagnosed with Plasmodium falciparum
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malaria. Among the TB patients, 290 died (15.2%), of which 27 were HIV positive, and
three had malarias. The results show that the rate of TB/HIV coinfection was high
(37.4%) among TB patients. The mortality rate among TB patients was found to be
15.2%.
Hamusse, Demissie, Teshome, and Lindtjorn (2014) investigated a 15 year trend
in treatment outcomes among patients with pulmonary smear-positive tuberculosis
(PTB+) registered between 1997 and 2011 in Arsi, Central Ethiopia. The area of Arsi has
one hospital and 73 health centers scattered through 23 districts. The population of the
area was 3.1 million. A retrospective study was employed to audit TB treatment
outcomes for PTB+ cases registered between September 1, 1997, and August 31, 2011. A
total of 14,221 cases were evaluated. From this figure, 11,888 (83.6%) were successfully
treated across the region. The rate of treatment success ranged from 69.3 to 92.5%,
default rate ranged from 2.5% to 21.6%, the failure rate from 0% to 3.6%, and the death
rate from 1.6% to 11.1%. The trend of treatment success rate increased from 61% to 91%
with an increase in DOTS coverage from 18% to 70% over the study period. Both default
and death rates decreased from 29.9% to 2.1%, and 8.8% to 5.4% respectively over the
15-years period. Logistic regression analysis of the data indicated that patients age >25
years, re-treatment cases, TB/HIV co-infected cases, and patients with no contact were
associated with unsuccessful treatment outcomes. The authors opined that the low
treatment success rate among retreatment cases could be attributed to the high incidence
of MDR-TB among the group.
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Sunday et al. (2014) provided the results of a retrospective study involving 965
patients who tested positive for tuberculosis and were enrolled in a direct observation
therapy program. The results showed an 85.5% success rate of completing the treatment
with 477 patients having completed their treatment (52.2%), 304 cured (3.3%), 87 died
(9.52%), 36 (3.94%) were transferred out, and 0.11% having failed to complete the
treatment. Logistic regression analysis by the authors showed that location of the
treatment center and treatment category was significantly associated with favorable
treatment outcomes.
The studies by Gao et al. (2013), Valadas et al. (2013), Sunday et al. (2014), and
Hamusse et al. (2014) are relevant to my studies in that they attempt to investigate those
patient-associated factors that influence TB incidence and treatment success rate using
quantitative retrospective cohort studies.
Critique of Methodology in Selected Articles
A review of the studies from Table 1 above shows that majority of them used
retrospective study design with the exception of Vijay et al. (2010) which used casecontrol study design. A variety of statistical methods were used ranging from descriptive
statistics (Kangbai & Koroma, 2013; Williams, 2010) to inferential statistics such
bivariate and multivariate logistic regression (Endris et al., 2014; Gadoev et al., 2014;
Getahun et al., 2013; Jemal et al., 2015; Sunday et al., 2014), chi-square, (Demeke et al.,
2013; Hamusse et al., 2014; Syed, 2014), Kaplan-Meier survival analysis, and
multivariate Cox proportional hazards analysis (Tolosie et al., 2014).
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Table 1 reveals that there were variations among the studies with respect to
sample size used. The sample size of the studies ranged from 417 (Endris et al., 2014) to
107,380 (Gadoevet al., 2015). With the exception of three studies (Gadoevet al., 2015;
Getahun et al., 2013; Hamusse, et al., 2014) the sample sizes in all the studies reviewed
were between 417 and 2,958 participants. For example, Endris et al. (2014) conducted a
retrospective study involving 417 participants from a DOT center in Ethiopia. The
measures examined were: sex, age, residence, type of TB, HIV status, successful
treatment, default, and death rates. Even though the authors observed a 94.8% treatment
success rate, they did not observe any statistically significant association between TB
patient characteristics and unsuccessful treatment outcome using multivariate logistic
regression analysis. The weakness of this study is that no covariate was investigated to
determine their contribution to treatment outcome. It is therefore not surprising that the
authors failed to establish any association between patient factors and treatment outcome.
Another weakness is that the study was undertaken in only one DOTS center. As a result,
the outcome of the study cannot be extrapolated to the general Ethiopian population.
Sunday et al. (2014) used a retrospective study design with 965 participants to
investigate treatment outcomes among TB patients at a DOTS center in southwestern
Nigeria. The parameters investigated were- patient’s age, sex, location, type of TB and
treatment outcome. They used descriptive statistics and bivariate and multivariate
logistics regressions to analyze their data. This study is prone to bias, as a large
proportion of the data was eliminated because of incomplete information on data points.
About 33.5% (486) of data were deleted as a result missing information. Another

54
weakness is that the authors did not control for covariates, as there was no information on
education, occupation, housing, and other socioeconomic variables in the registry.
The only two studies that I found on the subject done in Sierra Leone as shown in
Table 1 did not use any multivariate method. The study by Kangbai and Koroma (2013)
was a large population-based study with a sample size of 2,958. The sample size was
sufficiently large enough with a longer period of implementation (18 years) for valid
analysis. However, the study conducted by Williams (2010) did not include any sample
size. The author only presented summary statistics indicating proportions of treatment
outcomes. It is, therefore, difficult to replicate the study thereby raising questions about
its validity. In both studies, the major weakness was their over-reliance on descriptive
statistics whose output does not permit generalization of the outcome on the general
population from which the samples were drawn. In addition, the authors in both studies
just focused on the program success rate without any reference to patient factors that may
influence the treatment success rate. They also failed to address any confounders that
they controlled that might affect treatment outcomes.
It is apparent from Table 1 that majority of the studies entailed retrospective study
design using secondary data. The two main country-specific studies on TB in Sierra
Leone did not use inferential statistics, which makes the generalization of the outcome on
the population impossible. Most of the studies did not include any discussion of how
sample and effect size were determined and chosen. Sample size calculations and sample
selection are crucial, as they help in replication of the study for validity purposes. It will
also help in reducing Type II errors in power analysis. The lack of measurement of
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confounders in the analysis of exposure variables in the studies above introduces the
likelihood of bias in epidemiological studies. Therefore, my research will attempt to
investigate the effect of patient factors such as age, HIV status, gender, and TB category
that influence treatment outcomes among TB patients, which were not addressed by the
studies mentioned in Table 1 above. The study will also attempt to control for other
covariates such as education, geographic location and marital status that might affect the
study outcome.
Summary and Transition
In Chapter 2, I provided a comprehensive review of the literature that is available
relating to the present research study. The literature search strategy was well defined to
include the keywords, terminology, and inclusion and exclusion criteria, as well as the
process of review. This was necessary in order to show that the information included has
been systematically evaluated for the purpose of providing the most extensive data
available. Keywords and terminology were included in order to allow for the replication
of this search strategy to further provide validity to the results. This was followed by a
review of the literature selected to define and justify the use of the Andersen’s behavioral
model of health services utilization ((Li et al., 2015).
After providing justification for the framework, the literature review then
followed the guidelines to provide a review of the literature associated with the factors
influencing the utilization of health care services. This provided the reader with the most
recent findings in the field of research associated with the utilization and compliance of
health care treatments. Becoming more narrowly directed towards the present study, the
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literature review then transitioned into literature available regarding the implementation
of DOTS This led to a general description of the directly observed therapy protocol that
will become more specifically related to the study as the researcher presents data
regarding the studies that relate to research variables (independent variables: age, gender,
HIV status, category TB, and dependent variable: treatment completion). This was
followed by a review of previous studies that have utilized similar tactics to collect data
in health care research.
In closing, I have supported this literature review by a systematic process of
review to alleviate any potential for bias. I have provided evidence both in support and
refuting the proposed hypothesis and research questions. It was not my intention of the
literature review to answer the research questions. However, it was my intention to
provide a solid understanding of the researches that had been conducted and to guide the
present study towards adding to the available knowledge as opposed to repeating
previous studies. This will add credibility to the present research through the guidance, as
well as help in the process of implementing appropriate adaptations to the primary
delivery methods of medication to the patients who have tuberculosis in Sierra Leone and
to expand these programs to other regions as it is seen appropriate.
Moving forward from the literature review portion of the present research, I
focused on the research methodology in Chapter 3 based on the retrospective quantitative
discussion that has been supported by the currently available literature. The chapter will
include sections that will describe the study design and set out eligibility criteria for
sampling. There will also be sections on the study setting, sampling procedure, as well as,
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sample size determination. The chapter will also include sections on data collection and
management, statistical analysis, review of the research questions and hypothesis, and
ethical considerations to protect participants’ privacy and rights.
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Chapter 3: Methodology
Introduction
The main purpose of this study was to investigate the effect of patient
characteristics on the completion of TB treatment regimen among patients enrolled in the
DOTS program in Sierra Leone. Several factors influence successful TB treatment,
including the availability of drugs, access to health care services, and several patient
factors (Elkomy et al. (2013). The focus of this study was to investigate the patient
factors that may hinder TB treatment completion irrespective of the availability of drugs
as accorded by the DOTS program. In the study, I used a retrospective, longitudinal
quantitative design by analyzing secondary data gathered on TB patients undergoing
treatment at four regional DOTS centers in Sierra Leone.
I recruited the study participants from patients who had enrolled in the DOTS
program between January 2013 and December 2015. This chapter will be organized into
three main subheadings: research design, methodology, and threats to validity. In the
section on research design, I will identify the study design and describe the variables that
were investigated. In the section on methodology, I will elaborate on the target
population, state the sample frame, and explain how I drew the samples from the
population and determined the sample size for the study. The section will also include an
explanation of how I accessed the data and what permissions I sought or was required to
access the data. In the final section, I will address the threats to validity and ethical
considerations in data access and handling.
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Research Design and Rationale
The independent variables of interest that I investigated in this study were
patient’s age, gender, HIV status, and TB-case category. The effect of each variable was
tested on the dependent variable, treatment completion, among patients enrolled in the
DOTS program in Sierra Leone. However, the tested variable was controlled for any
effect of education, geographic location of the DOTS center, and marital status on
treatment completion.
I used a retrospective, longitudinal quantitative design in this study to analyze
data collected on TB patients between 2013 and 2015. In was evident from the literature
review that a majority of the researchers used a retrospective, longitudinal design to
assess the effect of DOTS programs on treatment outcomes (Demeke et al. 2013; Endris
et al., 2014; Gadoev et al., 2014; Sunday et al., 2014; Syed, 2014) and that using
secondary data reduces time constraints and maximize sample size (Getahun et al., 2013;
Hamusse et al. 2014;). A longitudinal design involves conducting several observations of
the individual characteristics relative to interacting factors over a long period of time
(Aschengrau & Seage III, 2014). This design enables researchers to observe changes in
the characteristics of the subjects relative to an external factor or treatment. A
retrospective, longitudinal design was appropriate for this study because the effect of TB
treatment outcome can only be realized over a long period of time. In the case of TB, it
takes at least 6 months before a conclusion can be reached about the efficacy of the
treatment (Munro et al., 2007). Since a longitudinal design entails examining data at
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different points in time, there is the possibility to establish temporal effect to the
outcome.
One of the disadvantages of longitudinal design is the time required for the
repeated observations to be completed. In order to address this shortcoming, I used
secondary data that were collected during the period between 2013 and 2015. Even
though researchers have no control over the parameters that are included in the data, as
well as the method of data collection and handling, using secondary data can save a lot of
time and resources (Kelder, 2005). Secondary data from population-based national
surveys provide a large pool of sample size that can be viewed as representative of the
population. The use of secondary data also requires less ethical scrutiny as it does not
expose study subjects to more harm due to treatment exposure (Kelder, 2005).
Based on the literature search and the above rationale, I used a retrospective,
longitudinal quantitative design since the advantages of using the design outweigh its
shortcomings. I analyzed secondary data from four DOTS centers in Sierra Leone that
were collected, de-identified, and archived for reference purposes. I used multiple logistic
regressions to determine if there was any association between my independent variables
of age, gender, HIV status, and TB-case category and my dependent variable of treatment
completion, while controlling for the effect of education, marital status, and geographic
location.

61
Methodology
Target Population
I undertook this study in Sierra Leone, West Africa (see Figure 1 below).
According to the 2015 national population census report (provisional), the population of
Sierra Leone stands at 7,075,641 (Statistics Sierra Leone, 2016). Because of time and
logistical constraints, this study was carried out in four main population centers
representing each of the four political divisions of the country: Freetown in the Western
Area; Makeni, in the Northern Province; Bo, in the Southern Province; and Kenema, in
the Eastern Province. The population of Freetown is recorded as 1,050,301, which makes
up about one-seventh of the country’s total population.
Following the integration of the National Leprosy Control and TB control
programs in 1990, the National Leprosy and Tuberculosis Control Program (NLTCP)
started implementing the WHO-recommended DOTS program (Africa Health
Observatory, 2014). The aim of the NLTCP was to reduce both leprosy and TB burden
by increasing access to case diagnosis, disease treatment, and management Africa Health
Observatory, 2014). As a result, the number of DOTS centers was increased from 116 to
148 in 2009 and 2010 respectively (Africa Health Observatory, 2014).
The main chest clinic located at the central Freetown Connaught Hospital is the
major DOTS center in the country, and it accommodates the majority of the TB patients
in the country . It was one of the four study sites for this research.
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Figure 1. Map of Sierra Leone showing the four geographic areas for the study. Retrieved
from https://www.google.com/search?q=map+of+sierra+leone+showing+provinces
The city of Makeni has a population of 126,059 people and is the hub of the
Northern Province (Statistics Sierra Leone, 2016). The Stocco Leprosy/TB Hospital is the
main DOTS center in Makeni that was included as a site for data collection for this study.
The other DOTS center that was considered for data collection is situated at the Bo
Government Hospital. The city of Bo is the largest population center in the Southern
Province with a population of 173,905(Statistics Sierra Leone, 2016). The final study site
was located at Kenema city site (Kenema Government Hospital), in eastern Sierra Leone.
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Sampling and Sampling Procedure
The design of this study required the use of archived secondary data containing
information on all the patients who attended the DOTS program at the four study sites.
The NLTCP database also provided the general countrywide TB profile. . The patient
records contained information on patients’ demographics, TB treatment administered,
HIV-status, HIV medication, TB-case category, daily attendance at the DOTS center, and
treatment outcome.
Sample frame. The prevalence of the number of TB cases in Sierra Leone is
estimated as 574 per 100,000 population (Africa Health Observatory, 2014). Based on
this estimate, the total number of people with TB can be projected as 40,614 with the
current population of 7 million. As a consequence, the proportion of the TB population in
the four study sites was inferred from this number. Based on the populations of the cities
mentioned in the previous section, I projected the prevalence of TB in Freetown as 6,028;
Makeni as 724; Bo as 998; and Kenema as 1,150. The combined prevalence of TB in the
four cities accounted for 22% of the total TB prevalence in the country. Therefore, the
data were a very good representation of the study population.
In addition, I selected samples from the data based on the inclusion/eligibility
criteria outlined herein. Participants in the study were selected only from the four study
sites of Freetown, Makeni, Bo, and Kenema. Furthermore, only patient records of those
who attended these centers between January of 2013 and December of 2015 were
considered eligible for the study. Data from all other DOTS centers outside of these
locations and timeframe were not included in the study.
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Power analysis/sample size calculation. I used OpenEpi version 3.01 (Dean,
Sullivan, & Soe, 2014) to determine the sample size of the population. Since each
independent variable affects the dependent variable differently, I used the cross-sectional
and cohort design model OpenEpi software to calculate my sample size. The model was
suitable for calculating sample size for cohort studies such as the retrospective cohort
study I conducted.
In determining the sample size, I made several assumptions about the study
population. The assumptions were made about the OR of the dependent variable with
respect to each independent variable, the ratio of unexposed to the exposed, and the
percent of unexposed with the outcome. I searched the extant literature to provide
information on the contribution of each primary covariate to the odds ratio of the
dependent variable. I could have determined the sample size for each independent
variable based on its contribution on the OR of the dependent variable. From the results, I
would have chosen an independent variable that had contributed the smallest OR, and
hence, the largest sample size for my study. To circumvent repetition, I decided to search
the literature and choose the smallest OR contributed by one of my independent variable
on the outcome variable and determined my sample size. Based on the literature, I chose
the minimum OR that would yield the maximum sample size for the study. The
covariates of gender, HIV status, geographic location, and TB-case category provided
useful information to guide in the selection of OR for the determination of the sample
size.
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Gender of the patient is well documented as a risk factor that contributes to the
successful completion of TB treatment for males. Gadoeve et al. (2015) concluded that
gender is an important factor that contributed to unfavorable treatment outcome
(treatment not completed). Their results indicated that the odds of loss to follow-up (not
completing treatment) are 1.5 times higher among males compared to females and that
there is 1.8 times greater odds of treatment completion among females compared to
males. A similar OR was arrived at by Yen et al. (2015), who recorded 1.65 odds of
treatment completion among females compared with males.
The built-in environment is well documented as a major determinant of health,
and the location where TB treatment takes place has been cited as a major factor for
treatment completion (Sunday et al., 2014). Several authors have shown a significant
association between the place of TB treatment and successful treatment outcome (Gadoev
et al., 2015; Getahun et al., 2013; Sunday et al., 2014; Syed, 2014). The observed
association in these studies ranged from 1.5 to 4.77.
Another important variable that contributes to treatment is TB-case category.
Sunday et al. (2014) observed 5.14 odds of treatment completion among new TB patients
who enrolled in the program for the first time compared to those that are non-new
patients such as retreatment cases, defaulted patients, and failed patients. Gadoev et al.
(2015) and Yen et al. (2013) recorded ORs of 1.67 and 2.3 for unfavorable treatment
outcome among non-new TB cases in their studies.
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Table 2
Sample Size Calculation
Sample size for cohort studies
Two-sided significance level(1-alpha):

95

Power(1-beta, % chance of detecting):

80

Ratio of sample size:
7
(Unexposed/Exposed):
Percent of unexposed with outcome:

80

Percent of exposed with outcome:

89

OR:

2

Risk/prevalence ratio:

1.1

Risk/prevalence difference:

8.9
Fleiss with CC

Sample Size – Exposed

170

Sample Size - Non-exposed

1,188

Total sample size:

1,358

Based on the above literature review, the OR used to calculate my sample size
ranged from 1.5 to 5.14. I, therefore, decided to use the median OR of 2; which fell
between 1.8 and 2.3, to determine my sample size. The OR was used to calculate the
minimum sample size required to generate sufficient power for this study. Since my
hypothesis is a two-tailed test, I used the 95% CI and an 80% power to determine my
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sample size. The result of the OpenEpi is summarized in Table 2. The output shows that I
needed a total minimum sample size of 1,358 samples.
Sampling procedure. I used a systematic probability sampling technique to
select my sample (1,358) from the population. In systematic sampling, the researcher
chooses the N th unit of the population after choosing the first sample randomly from the
sampling population (Patton, 2002). Probability sampling increases representativeness.
This is because each unit has an equal and independent chance of being included in the
sample (Patton, 2002).
The sample interval (Nth sample) for each study site is determined based on the
sample size required and the total number of TB cases. Based on the proportion of the
number of TB cases in each city and sample size analysis, the required sample sizes for
Makeni, Bo, Kenema, and Freetown are 200, 200, 200, and 800 respectively (see section
on power analysis above). In selecting a representative sample for Makeni, the sample
interval is first determined, which is four (724/200). I randomly selected the first sample
from the first four records. From that point, I selected every fourth record from the
patient’s hospital register until the total of 200 samples was selected. The procedure was
repeated for BO, Kenema, and Freetown. However, I overdrew each sample slightly to
make accommodation for any missing data. The total sample drawn was therefore 1,794
cases.
Data Collection and Management
I used secondary data to conduct my research. The process involved reviewing
patient data collected between 2013 and 2015 at the TB treatment centers described in the
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aforementioned sections. Records on TB treatment are stored on patient hospital cards, as
well as the hospital registers. To gain access to the data, I obtained permission from the
Ministry of Health and Sanitation to undertake the study. I made preliminary contacts
with the ministry and presented my premise to them. I received written assurance that I
will be permitted to undertake the study and collect the necessary data whenever I deem
it necessary. After my proposal defense and Institutional Review Board (IRB) approved
my research, I formally request permission to conduct the research. The MOHS then
granted me the formal permission to undertake the research (see Appendix A).
Most hospitals still maintain hard copy hospital records which have to be
painstaking combed to extract the required information. The central National Leprosy and
Tuberculosis Program maintain some data in Word or Excel format that contains
summary information from all treatment centers. However, they did not contain
individual patient variables which are the subject of this investigation. I had to extract the
information manually from the hospital registers to record them into excel.
Instrumentation and Operationalization of Concepts
The instrument for the data collection was individual patient’s hospital records
and hospital registers from the period 2013 through 2015. Each treatment center
maintains both patient records and hospital registers that contain information on all the
patients. The Monitoring and Evaluation (M & E) Unit of each center collates
information on the DOTS program and send it to the NLTCP in Freetown. The M & E
personnel in each center gives a unique code to each patient and transfers all patient
information from the patient’s hospital record into the hospital registry without any
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patient identifiers. The code book is then kept by a senior M & E officer separately from
the hospital register. The M & E officers come to the treatment area periodically (weekly
or biweekly) to update their information and their offices are located in different sections
of the hospital from the treatment area. All data for this study was, therefore, collected
from the de-identified information recorded in the hospital registers from each center.
This researcher, however, randomly checked few entries in the registry against patients’
hospital records to ascertain accuracy in data entry. This was done at a minimal level to
prevent compromising patient identity.
The covariates that were tested in this study were age, gender, HIV status, TBcase category, marital status, education, and geographic location. The outcome variable
was treatment completion. The variables will be measured based on the following
criteria.
Primary dependent variable. Treatment completion is measured as the number
of days of treatment or number of doses completed. For a person to be described as
having completed treatment, they must have continued their treatment for 168 days (6
months with 28 days in each month) or have taken 168 doses of their medication. Since
the outcome variable is measured in days on treatment, for the purpose of this study, the
outcome variable was dichotomized into < 168days/doses for those who did not complete
treatment and ≥168 days/doses for treatment completion. The variable was then coded as
1 = Yes (treatment completed) and 0 = No (treatment not completed).
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Independent variables.
Age. Age is recorded as the number of years from birth till the day treatment
started. The variable age will be divided into four useful categories. The four categories
were recorded thus: 0 = 0 to 20 years, 1 = 21 to 40 years, 2 = 41 to 60 years, and 3 = ≥ 61
years.
Gender. Gender were recorded as a dichotomous variable: 1 = male and 0 =
female.
TB-case category. All cases that are registering for TB treatment for the first time
and have not been on any previous anti-TB medication were referred to as new cases. All
other cases that are taking treatment for the second time including those that have
defaulted, retreatment cases, and cases that have failed treatment are described as nonnew. Therefore, the independent variable TB-case category is dichotomized into the
following: 1= new cases and 0 = non-new cases.
HIV-status. HIV status was recorded as a dichotomous variable in this study. It
was worth noting that it is the policy of NLTCP that all TB patients be tested for HIV
status. Therefore, all TB cases have a known HIV status. All TB cases that tested positive
for HIV are coded as 1 = HIV-positive and those that tested negative are coded as 0 =
HIV-negative.
Covariates.
Education. Education is measured as the level of attempted or attained at the time
of registering for treatment. The variable is recorded as a categorical variable into four
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categories: none = 0, some primary/primary education = 1, secondary education = 2 and
postsecondary education = 3.
Marital status. Marital status is described as either being married or not married
at the time of registration. The variable was recorded as a dichotomous variable: married
= 1 and not married = 0.
Geographic location. Data for this study were collected from four hospitals in
Freetown, Makeni, Bo, and Kenema. The four hospitals were divided into two geographic
categories. Freetown was described as urban and Makeni, Bo, and Kenema will be
described as rural. Therefore, the covariate geographic location was dichotomized into
rural = 0, and urban = 1.
Data Analysis
My main source of data was from the hospital registers. The information from the
hospital registers was supplemented by data from NLTBCP and patients’ hospital
records. I randomly cross checked some of the data entries in the hospital registers with
patient hospitals cards to ascertain that correct entry were done. The data were scanned
through and cleaned for missing or incomplete information.
Research questions. The data were used to provide answers to the following
research questions.
RQ1: Is there an association between age and TB treatment completion among TB
patients in Sierra Leone when adjusting for education, marital status, and
geographic location?
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H01: There is no association between age and TB treatment completion
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
H11: There is association between age and TB treatment completion
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
RQ2: To what extent does gender predict the likelihood of treatment completion
among TB patients in Sierra Leone when adjusting for education, marital status,
and geographic location.
H02: There is no difference in the odds of TB treatment completion
between men and women among TB patients in Sierra Leone when
adjusting for education, marital status, and geographic location.
H12: The odds of treatment completion are different for men and women
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
RQ3: Is there an association between TB-case category and TB treatment
completion among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location?
H03: There is no association between TB treatment completion and TB
category among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location.
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H13: There is an association between TB treatment completion and TB
category among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location.
RQ4: To what extent does HIV status predicts the odds of TB treatment
completion among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location?
H04: There is no difference in the odds of treatment completion between
HIV-positive patients and HIV- negative patients among TB patients in
Sierra Leone when adjusting for education, marital status, and geographic
location.
H14: The odds of treatment completion are different for HIV-positive
patients and HIV- patients among TB patients in Sierra Leone when
adjusting for education, marital status, and geographic location.
Analysis plan. Both descriptive and inferential statistics were performed using
SPSS version 21, to describe the data set and examined whether there existed any
relationship or association between the independent variables of age, gender, HIV status,
and TB-case category and the dependent variable of treatment completion. Since the
outcome variable and the independent variables were categorical, both bivariate logistic
regression and multiple logistic regressions were used to analyze the data (Forthofer, Lee,
& Hernandez, 2007). After the assessment of all independent variables in a bivariate
analysis, all independent variables that show a significant contribution to the outcome
variable were simultaneously modeled into the multiple logistic regressions. The model
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then tested the strength of each variable as a predictor of the outcome variable. By
identifying the predictor variables that have the most effect on treatment completion, the
care provider will be equipped to focus more attention on those individuals who are likely
not to complete their treatments.
Threats to Validity
The main problem for the researcher is to show that the outcome variable is not
influenced by outside forces other than those the researcher set out to investigate which
creates a threat to validity It is imperative that the researcher identifies such threats and
take steps to mitigate their effect. In general, there are two types of threats that may affect
quantitative research: intrinsic/internal and an extrinsic/external.
Threats to Internal Validity
Threats to internal validity are problems encountered in research that can be
controlled by the researcher if rigorous experimental or research procedures are followed
(Frankfort-Nachmias & Nachmias, 2008).. They arise from flawed research procedures,
and sometimes from the very experiences of study participants. They tend to negatively
influence the researcher’s ability to draw objective conclusions from the data being
collected (Creswell, 2009). They erode our confidence to categorically state the existence
of a relationship between our outcome variable and the predictor variables.
The aim of this study was to examine the effect of patient characteristics on
treatment completion among TB patients enrolled in the DOTS program in Sierra Leone.
Data were collected from four regional DOTS centers. The selection of these centers was
crucial, as it may pose a threat to the validity of the study. The participants in these
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centers may have different characteristics from the general TB population attending other
centers, thereby possibly affecting treatment outcomes. Furthermore, the selection of
samples within the treatment population in each center might also introduce selection bias
because the entire population will not be used for the study.
Selection bias was addressed in this study in multiple ways. First of all, the TB
population data estimates show that these four centers account for 22% of the entire TB
patient population in the country. That indicates that the selection of these centers gave a
fair representation of the patient characteristics in the country. Furthermore, participants
in the study were randomly selected from the available data set so that each patient in the
population had an equal probability of being included in the data thereby eliminating any
potential selection bias.
Experimental mortality another possible threat to validity that may be introduced
in this study is. Because TB is a chronic disease that requires longer duration for a cure,
there exists a threat to loss to follow-up. This is particularly important if there is a
differential drop-out among one group relative another. Since I am looking at secondary
data, differential mortality can also be introduced into the system due to missing data.
However, loss to follow-up had minimal effect in this study since I am looking at
secondary data that had been collected and we are not following the groups into the
future. Furthermore, since the data set is large, any differential dropout may be countered
by the sheer volume of the data. In addition, the existence of missing data can be random
and will not preferentially favor any group over the other.
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Threats to External Validity
As mentioned earlier, selection of the study locations is a possible source of bias,
and this may likely introduce a threat to external validity. Since the participants were
selected from only four DOTS centers, there is the possibility of erroneously
extrapolating the conclusions of the study outcome to the general TB population in the
country. The selection of the four DOTS centers was made with the intention to include
each geographic region in sample to so to increase representativeness. Even though these
centers represent one-fifth of the entire TB population, the sample might not be sufficient
enough to make generalization on the population. Because of the potential of this threat,
the outcome of this study should be applied with caution to the general TB population.
Ethical Considerations
In conducting research, the researcher has the fundamental responsibility not to
cause any harm or distress to the study participants (Creswell, 2009). This is achieved by
obtaining consent agreement from patients to participate in the research. The consent
agreement should explain in clear terms the right of participants to withdraw from the
research at any point they feel unconformable. The researcher should maintain the
dignity, and respect the privacy of subjects at all times (Resnik, 2015). That being said, I
upheld the highest virtue of academic integrity and respect for individual privacy at all
levels in data collection, analysis, and dissemination of the information.
The research proposal was submitted to the Walden Institutional Review Board
(IRB) to check for compliance with all ethical standards pertaining to study participants.
No data were collected on subjects until the IRB approved that the minimum standard
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was met to collect data for the study. The IRB approval number for this research is 1104-16-0376161. Furthermore, the study proposal was also submitted to the Ministry of
Health and Sanitation of Sierra Leone to request permission to undertake the study. The
type of variables and information needed for the study were clearly explained to the
Ministry officials. Data collection was only initiated after approval from both the Walden
IRB and the Ministry of Health and Sanitation for the study to commence.
The research was based on secondary data that were collected on patients
undergoing TB treatment in previous years. The data had been stripped of patient
identifiers before storage. Therefore, I did come into direct contact with any subject
during the course of the research. There were few instances where I attempted to access
patient’s hospital records with identifiers to verify data entry. However, this was a minute
fraction of the entire dataset and did not pose any risk be it physical, psychological, or
social to the safety of study subjects. In addition, I did not have any access and did not
make any deliberate effort to contact any of the patients involved.
Summary
In Chapter 3, I described the methodology employed in conducting this research. I
used a retrospective longitudinal quantitative design in this study with secondary data
from hospital registers. The targeted population was TB patients who underwent TB
treatment at four DOTS centers in Sierra Leone. In the chapter, I described how the
sample size was determined and how it was drawn from the target population. All
variables in the study were defined and their levels of measurement well defined. The
RQs addressed in the study were restated, and the analytical methods to answer the
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research questions were advanced. The various threats to validity were elucidated, as well
as and the how their effect on the outcome variable can be mitigated were outlined. The
steps taken to maintain patient confidentiality and maintain ethical research standards
were discussed. I will discuss the analysis of data and results of the findings in the
following chapter.
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Chapter 4: Results
Introduction
The primary purpose of this research was to investigate the relationship between
patient characteristics and treatment completion among TB patients under the DOTS
program in Sierra Leone. In this study, I selected four representative DOTS centers from
each of the four administrative regions of the country (Northern, Southern, Eastern
Provinces and the Western area). The specific objectives of the study were to investigate
how age, gender, TB-case category, and HIV status would predict the likelihood of
treatment completion, while controlling for marital status, education, and geographic
location as an indicator of access to health service.
This chapter will contain my analysis of data collected from four regional DOTS
centers in Sierra Leone. In the chapter, I will provide the general descriptive statistics of
the study participants, bivariate results on the contribution of individual covariates on the
outcome variable, and the results of a multiple logistic regression analysis that tested the
extent of the relationship between each covariate and the dependent variable while
holding other variables constant. The chapter will also contain results on the trend of
treatment completion from 2013 to 2015 in general and stratified by urban/rural location.
I tested the significance of the observed trend using a stratified logistic regression.
Data Collection and Management
I collected data for this retrospective study from four regional DOTS centers in
Sierra Leone after gaining Walden IRB approval to conduct the study. The sample
included patients who had received treatment from those centers between 2013 through
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2015. Based on my sample size calculation, as outlined in Chapter 3, the study required a
minimum of 1,358 participants, with 800 from Freetown Chest Clinic, 200 each from Bo
Government Hospital, Kenema Government Hospital, and Makeni Stocco Leprosy/TB
hospital respectively. The distribution of the sample was based on the proportional
prevalence of TB in the four administrative regions.
During data collection, I randomly selected a total of 1,794 cases from the
database as outlined in Chapter 3. Of these, 77 cases (4%) were recorded as transferred,
78 died (4%) during treatment, and six had missing variables. The final sample size that
was included in the analysis was 1,633 cases. Therefore, the sample size in the final
analysis was adequate, and even above the minimum sample determined in the power
analysis in Chapter 3.
Results
Summary Descriptive Statistics of Patient Characteristics
Table 3 shows the summary descriptive statistics of the characteristics of the
patients that I sampled in the study. The results indicated that among the 1,633 cases,
16.2 % fell within the age group 0–20 years, 54.9 % within 21–40 years, 22.0 % within
41–60 age group, and 6.3 % were greater than 61 years old. The mean age of the study
sample was 34.15 years ranging from 1 to 95 years and a SD of 15.50 years. More than
60 % of study participants were males, and 32.7% were females. The majority of cases
were HIV-negative 1,275 (78.1 %), 1,452 (88.9 %) were new cases of TB, and 983 (60.2
%) were not married.
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Table 3
Descriptive Statistics of Patient Characteristics
Patient characteristics
Age category
0–20 yrs
21–40 yrs
41–60 yrs
> 61 yrs
Missing
Total

Frequency

%

264
897
359
103
10
1633

16.2
54.9
22.0
6.3
.6
100.0

Gender
Female
Male
Total

612
1021
1633

37.5
62.5
100.0

HIV/TB status
Negative
Positive
Missing
Total

1275
317
41
1633

78.1
19.4
2.5
100.0

TB-case category
Non-new
New
Missing
Total

176
1452
5
1633

10.8
88.9
0.3
100.0

Marital status
Not married
Married
Missing
Total

983
631
19
1633

60.2
38.6
1.2
100.0
(table continues)
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Frequency

%

467
403
494
237
32
1633

28.6
24.7
30.3
14.5
2.0
100.0

Location
Bo
Freetown
Kenema
Makeni
Total

245
907
246
235
1633

15.0
55.5
15.1
14.4
100.0

Urban/rural
Rural
Urban
Total

726
907
1633

44.5
55.5
100.0

Year
2013
2014
2015
Total

554
561
518
1633

33.9
34.4
31.7
100.0

Patient characteristics
Educational level
None
Some primary/primary education
Secondary education
Postsecondary education
Missing
Total

The proportion of those participants with no education or some form of primary
education made up more than half of the sample, with 28.6 % with no education and 24.7
% with some/primary education. Those with secondary education made up 30.3 %, and
postsecondary education was 14.5 %. Fifty-five percent of the sample was selected from
Freetown and about 15 % each from the other three regions respectively. The percentage
of the total sample drawn was evenly distributed across the 3 years: 33.9%, 34.4 %, and
31.7 % for 2013, 2014, and 2015 respectively.
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Results of Bivariate Analysis of Patient Characteristics on Treatment Completion
I conducted a bivariate analysis to test the effect of each patient characteristic on
treatment completion. These results are presented in Table 4. The Chi-square test
measured the significance of the contribution. The results indicated that the age of the
patient (χ2 = 11.939, p < 0.008); gender (χ2 = 9.117, p < 0.003); HIV/TB status (χ2 =
13.565, p < 0.0001); educational level status (χ2 = 140.068, p < 0.0001); the location of
the treatment patient (χ2 = 28.975, p < 0.0001); and the year of the treatment status (χ2 =
42.129, p < 0.0001) significantly contributed to treatment completion as indicated by
their respective p values. However, TB-case category (χ2 = 1.410, p > 0.235) and marital
status (χ2 = 0.390, p < 0.0001) did not significantly influence the odds of treatment
completion among study participants.
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Table 4
Bivariate Analysis of Patient Characteristics for Treatment Completed (Yes or No)
Variables

Completed
Treatment
(No)

%

%

Total

Chi-square

108
281
126
44

40.9
31.3
35.1
42.7

59.1
68.7
64.9
57.3

264
897
359
103

χ2 (11.939)
p (0.008)

Female

241

39.4

371

60.6

612

χ2 (9.117)

Male

327

32.0

694

68.0

1021

p (0.003)

Non-new

54

30.7

122

69.3

176

χ2 (1.410)

New

511

35.2

941

64.8

1452

p (0.235)

Negative

411

32.2

864

67.8

1275

χ2 (13.565)

Positive

137

43.2

180

56.8

317

p (0.000)

Not married

342

34.8

641

65.2

983

χ2 (0.390)

Married

210

33.3

421

66.7

631

p (0.532)

None

232

49.7

235

50.3

467

Some

175

43.4

228

56.6

403

93

18.8

401

81.2

494

46

19.4

191

80.6

237

Age group
0–20 yrs
21–40 yrs
41–60 yrs
≥ 61 yrs

Completed
Treatment
(Yes)
156
616
233
59

Gender

TB-case category

HIV/TB
status

Marital status

Educational level
χ2
(140.068)
p (0.000)

primary/primary
education
Secondary education
Postsecondary
education

…………………………………………………………………………...(table continues)
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Variables

Completed
Treatment
(No)

Percent

Completed
Treatment
(Yes)

Percent

Total

Chi-square

Location
Bo
Freetown
Kenema
Makeni

90
325
105
48

36.7
35.8
42.7
20.4

155
582
141
187

63.3
64.2
57.3
79.6

245
907
246
235

χ2 (28.975)
p (0.000)

Urban/rural
Rural
Urban

243
325

33.5
35.8

483
582

66.5
64.2

726
907

χ2 (0.991)
p (0.319)

Year
2013
2014
2015

247
187
134

44.6
33.3
25.9

307
374
384

55.4
66.7
74.1

554
561
518

χ2 (42.129)
p (0.000)

Evaluating the Predictive Ability of the General Logistic Regression Model
I examined the ability of the model to predict the outcome variable correctly by
comparing a 2 X 2 classification table of the null model without predictors with that of
the model with all the predictors. The results are presented in Table 5. The results showed
that the logistic regression model correctly classified the outcome variable (treatment
completion) for 71.5% of the cases compared to 66.5% in the null model.
I also examined the omnibus test of model coefficient to see whether the addition
of predictors to the regression improved the baseline model. A chi-square test was used to
check the significance of the improvement of th model over the baseline model. The
result showed that the model was explaining more of the variance in the outcome variable
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(see Table 5). This was supported by the Nagelkerke pseudo R2 value which suggests that
the model predicts 18.2% of the variation in the outcome variable (see Table 5).
The Hosmer and Lemeshow (H-L) test for goodness of fit compares the observed
cases to the predicted cases by the logistic regression (Field, 2014). An H-L goodness of
fit greater than 0.05 shows that the model prediction is not statistically different from
observed cases( Field, 2014). The results from Table 5, therefore, demonstrate that the
model is a good fit for the data with p =0.721 > 0.05. The results of the above evaluation
show that the data fits the regression model and the model can classify the outcome
variable correctly for the majority of the cases.
Table 5
Table of Predictive Coefficients
Tests
Chi-square

X2 = 217.98, df = 15, p < .0001

Nagelkerke R2

0.182

Overall 2 x 2 Classification

76.1 [66.5]

Hosmer & Lemeshow (H-L)

(X2 = 5.34, df = 8, p > 0.721).

Testing Assumptions
The results of a logistic regression are reliable only if certain assumptions are not
significantly violated (CITE). Therefore, I tested the following assumptions for violation.
Multicollinearity. I assumed that the correlation between two or more
independent variables should not be significantly strong. Multicollinearity is suspected to
be violated when the coefficients of correlation matrix between two variables are greater
than 0.8 (Green & Salkind, 2011). The results from the correlation matrix analysis show
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that the highest coefficient of 0.685 was obtained between the age category (1) and age
category (2). Therefore, the assumption of multicollinearity was not violated in the study.
Linearity of the logit. Even though logistic regression does not require linear
relationship between the independent and dependent variables, it does assume that the
independent variables are linearly related to the log odds (Green & Salkind, 2011). If this
assumption is violated, the test underestimates the strength of the relationship and easily
rejects the alternative hypothesis as the relationship is not significant (Green & Salkind,
2011). The results from Table 5 show that this assumption was not violated since the H-L
goodness of fit test indicated that the data fits perfectly well into the model, X2 = 5.34, df
= 8, p > 0.721. This was further supported by the Nagelkerke R2 which shows that the
model accounts for 18.2% of the variance observed in the outcome.
Influential cases. The model assumes that there should not be cases that have a
substantial impact on the model (Field, 2014). This might be an indication of data error
and might negatively skew the regression result. This assumption is said to be violated
when an estimate of Cook’s distance is greater than one (Field, 2014).. The results from
the Cook’s distance statistics show that the highest value for Cook’s distance is 0.00014
< 1.00. Therefore, the assumption was not violated, and no one variable had an unduly
influence on the model.
Addressing the Research Questions and Hypothesis from the Results
The univariate analysis indicated that age, gender, HIV/TB status, education,
location, and year of treatment individually influenced treatment completion without
holding other variables constant. In other to answer the research questions while
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controlling for confounding variables, multivariate logistic regression analysis was
conducted. All covariates were entered simultaneously into the model. The results of the
multiple logistic regression are presented in Table 6 and discussed in the following
sections.
Research Question 1
RQ1: Is there an association between age and TB treatment completion among TB
patients in Sierra Leone when adjusting for education, marital status, and
geographic location?
H01: There is no association between age and TB treatment completion
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
H11: There is an association between age and TB treatment completion
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
The result from the univariate analysis indicated that age had a significant
influence on the likelihood of treatment completion without controlling for other
covariates. A multiple regression analysis was therefore conducted to investigate the
association between age and treatment completion while controlling for other covariates
(gender, HIV status, TB-case category, marital status, education, and location). The
results from Table 6 shows that the OR were not statistically significant for the different
age groups (21 – 40 years [OR = 1.08, p = 0685], 41 – 60 years [OR = 1.34, p = 0.168],
and ≥ 61 [OR = 1.35, p = 0.276]). Therefore, the null hypothesis of no association
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between age and TB treatment completion cannot be rejected in favor of the alternative
hypothesis of an association between age and TB treatment completion while adjusting
for the other covariates (gender, HIV status, TB-case category, marital status, education,
and location).
Even though the bivariate result indicated some association between age and
treatment completion, the multiple logistic regression shows that there is no significant
association between any of the age groups and treatment completion while adjusting for
all the other variables (gender, HIV status, TB-case category, marital status, education,
and location).
Research Question 2
RQ2: To what extent does gender predict the likelihood of treatment completion
among TB patients in Sierra Leone when adjusting for education, marital status,
and geographic location.
H02: There is no difference in the odds of TB treatment completion
between men and women among TB patients in Sierra Leone when
adjusting for education, marital status, and geographic location.
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Table 6
Multiple Logistic Regression Analysis of Patient Characteristics and Treatment
Completion with OR, 95% CI, Wald and P values (N= 1553)
Variable

%a

OR

Age category
0–20 yrs
21–40 yrs
41–60 yrs
≥ 61 yrs

15.71
55.82
21.96
6.50

1.00

Gender
Female
Male

37.15
62.85

1.00

Non-new
New

1.08
1.34
1.35

95% CI
Lower
Upper

Wald

P

2.831

0.418

0.76
0.89
0.79

1.52
2.02
2.31

0.17
1.90
1.16

0.685
0.168
0.276

1.14

0.89

1.44

1.07

0.301

10.95
89.05

1.00
0.80

0.55

1.18

1.26

0.261

HIV/TB
status
Negative
Positive

80.10
19.90

1.00
0.46

0.83

10.51

0.001

Marital status
Not married
Married

60.27
39.73

1.00
0.93

1.57

1.97

0.160

28.53
25.11

1.00
1.36

1.01

1.83

3.96

0.047

31.49

4.78

3.43

6.67

84.98

0.000

14.87

4.65

3.07

7.05

52.55

0.000

TB-case category

Educational level
None
Some
primary/primary
education
Secondary
education
Postsecondary
education

0.62

1.21

……………………………………………………………………………(table continues).
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Variable

%a

OR

95% CI
Lower

Upper

Location
Bo
Freetown
Kenema
Makeni

15.13
56.34
14.29
14.23

1.17
0.88
2.31

0.84
0.59
1.47

1.62
1.32
3.61

Rural/urban
Rural
Urban

55.5
45.5

1.00
0.86

0.62

1.19

Year
2013
2014
2015

33.74
34.06
32.20

1.00
1.13
1.81

1.93
3.21

a

Wald

P

0.86
0.38
13.31

0.354
0.538
0.000

1.00

1.48
2.41

0.354

8.10
36.35

0.004
0.000

Nonmissing percent frequencies of covariates in the logistic regression model.
H12: The odds of treatment completion are different for men and women
among TB patients in Sierra Leone when adjusting for education, marital
status, and geographic location.
The results from the logistic regression analysis from Table 6 show that gender

does not significantly predict the odds of treatment among TB patients while controlling
for age, HIV status, TB-case category, marital status, education, and location (OR =
1.14, 95% CI [0.89, 1.44], p = 0.301). The results show that we will reject the alternative
hypothesis of significant difference in the odds of treatment completion between men and
women and accept the null hypothesis of no difference in the odds of treatment
completion between men and women when adjusting for age, HIV status, TB-case
category, marital status, education, and location.
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Research Question 3
RQ3: Is there an association between TB-case category and TB treatment
completion among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location?
H03: There is no association between TB treatment completion and TB
category among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location
H13: There is an association between TB treatment completion and TB
category among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location.
Table 6 shows the results of the multiple logistic analyses conducted to test
whether there is an association between TB-case category and TB treatment completion
when controlling for other covariates (age, gender, HIV status, marital status, education,
and location). The OR for new cases compared to non-new cases is statistically not
significant, OR = 0.80, 95% CI [0.55, 1.18 (p < 0.261. Therefore, the null hypothesis of
no association between the predictor variable TB-case category and TB treatment
completion cannot be rejected in favor of the alternative hypothesis of the existence of
significant association. Thus suggesting that the variable TB-case category in the model
does not predict the outcome variable treatment completion as there is no association
between the two variables, after controlling for other covariates (age, gender, HIV status,
marital status, education, and location).
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Research Question 4
RQ4: To what extent does HIV status predicts the odds of TB treatment
completion among TB patients in Sierra Leone when adjusting for education,
marital status, and geographic location?
H04: There is no difference in the odds of treatment completion between
HIV-positive patients and HIV-negative patients among TB patients in
Sierra Leone when adjusting for education, marital status, and geographic
location
H14: The odds of treatment completion are different for HIV-positive
patients and HIV-negative patients among TB patients in Sierra Leone
when adjusting for education, marital status, and geographic location
A multiple logistic regression was conducted to examine to what extent does HIV
status correctly predicts the odds of treatment completion among TB patients. The results
of the analysis are presented in Table 6. It is evident from the results that the odds of
treatment completion among HIV-positive TB patients were 0.62 times less likely
compared with those that are HIV-negative assuming all other predictor variables are
held constant. The association between HIV status and treatment completion was
statistically significant, OR = 0.62, 95% CI [0.46, 0.83] and the Wald (10.51) associated
with the variable was also statistically significant (p <0.001). That means HIV-positive
patients were 38% less likely to complete their treatment compared to their counterparts
that were HIV-negative. Therefore, the null hypothesis of no difference in odds of
treatment completion can be rejected in favor of the alternative hypothesis of the
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existence of a a significant difference in the odds of treatment completion between HIVpositive and HIV-negative patients while controlling for age, HIV status, TB-case
category, marital status, education, and location.
Covariates
The results of the multiple logistic regression in Table 6 also contain covariates
(marital status, education, and location) and year of treatment. The odds of treatment
completion among those that were married was not statistically significant compared with
those that were not married, OR = 1.21, 95% CI (0.93, 1.57), p = 0.160. However, the
odds ratio of treatment completion is significant with regards to education and location.
The odds ratio of treatment completion is significantly higher among those with some
primary/primary education (OR = 1.36, p = 0.047), secondary education (OR = 4.78, p
0.0001) and postsecondary education (OR = 4.65, p = 0.0001) compared with those with
no education. With regards to geographic location, those living in rural areas were 0.86
times or 14 % less likely to complete their treatment compared to those that live in the
urban area. However, the result is not statistically significant, OR = 0.86, 95% CI (0.62,
1.19), p = 0.354. When individual DOTS centers were compared with each other, those
receiving treatment in Makeni were 2.31 times (131%) more likely to complete their
treatment compared with those living in Bo, OR = 2.31, 95% CI (1.47, 3.61), p = 0.0001.
There was no significant difference in treatment completion between those receiving
treatment in Kenema and Freetown when compared with Bo.
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Yearly Trend in Treatment Completion
Figure 2 shows the overall yearly trend in treatment completion. It is evident that
treatment completion improved over the years. There was a decline in the number of
those that did not complete their treatment from 48.4%, in 2013 to 25.4% in 2015 while
those that completed treatment increased from 51.6% to 74.6% respectively.

Figure 2: Yearly trend in treatment completion.
The difference in trend between the years was tested to see whether it is
significant. The OR for TB treatment completion in 2014 and 2015 were significantly
higher compared to 2013. The OR for 2014 and 2015 were respectively OR = 1.48, 95%
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CI (1.13, 1.93), p = 0.004); and OR = 2.41, 95% CI (1.81, 3.21), p = 0.0001. The results
suggest that the odds of the likelihood of treatment completion increased by 48% in 2014
and 141% in 2015 compared to 2013 respectively.
Stratified Multiple Regression Analysis Based on Location
The results of the general logistic regression showed that HIV status of the
patient, his or her educational level, the location of the treatment and the year of the
treatment could predict the likelihood of TB treatment completion in the general sample.
A stratified multiple regression was therefore conducted to ascertain the predictive ability
of the covariates with respect to the location. The sample was dichotomized into urban
and rural location and modeled into a multiple regression analysis. The results are
presented Tables 7 and 8 and discussed in the following sections.
Multiple Regression Analysis of Patient Characteristics in Rural Areas
Table 7 shows the results of a multiple regression analysis of treatment
completion based on rural residency. The total number of cases sampled was 678 with
complete data points. The results are similar to the general logistics regression for the
entire sample. The results show that HIV status, education, and year of treatment were
significant in predicting treatment completion among residents in the rural areas. The
odds of the likelihood of treatment completion among HIV - positive patients was 48%
less likely compared to those that were HIV – negative, OR = 0.52, 95% CI (0.31 0.88), p = 0.014.
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Table 7
Stratified Multiple Logistic Regression Analysis of Treatment Completion (Rural) with
Odds ratio (OR), 95% CI, Wald and P values (N= 678)
Variable

%a

OR

Age category
0–20 yrs
21–40 yrs
41–60 yrs
≥ 61 yrs

18.73
51.92
22.12
7.23

1.00

Gender
Female
Male

40.27
59.73

1.00

Non-new
New

95% CI
Lower
Upper

Wald

P

0.52
0.61
0.94

1.49
2.19
4.64

0.24
0.21
3.23

0.624
0.650
0.072

0.94

0.65

1.35

0.11

0.744

10.62
89.38

1.00
0.66

0.35

1.23

1.72

0.190

HIV/TB
Status
Negative
Positive

86.43
13.57

1.00
6.05

0.014

Marital status
Not married
Married

59.73
40.27

0.88
1.16
2.08

TB-case category

Educational level
None
Some
primary/primary
education
Secondary
education
Postsecondary
education

0.52

0.31

0.88

1.00
0.87

0.57

1.34

0.40

0.529

32.01
21.68

1.00
1.27

0.80

2.01

1.06

0.304

0.09

5.19

3.10

8.68

39.36

0.000

16.22

8.00

4.07

15.73

36.33

0.000

………………….…………………………………………………….(table continues)………
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Variable

%a

OR

Location
Bo
Kenema
Makeni

34.66
32.74
32.60

1.00
0.95
2.58

95% CI
Lower
Upper

0.62
1.63

1.44
4.10

Wald

P

0.07
16.18

0.794
0.000

Year
32.01
1.00
2013
33.48
2014
1.02
0.66
1.55
0.01
0.942
34.51
2015
1.84
1.18
2.87
7.21
0.007
a
Nonmissing percent frequencies of covariates in the logistic regression model.
Education had significant impact on treatment completion among residents in
rural areas. The odds ratios for those with some primary/primary education, secondary
education, and post-secondary education are OR = 1.27, 5.19, and 8.00 respectively. This
shows that the likelihood of treatment completion improved from 1.27 times among those
with some primary/primary education to eight times among those with post-secondary
education when compared with those with no education.
Table 7 also shows that within the rural centers, patients that received treatment in
Makeni had 2.58 times likelihood to complete their treatment compared with those that
received treatment in Bo. There was no significant difference between those that received
treatment in Kenema compared with those that received treatment in Bo. Overall,
treatment completion improved slightly over the years as the likelihood of completing
treatment in 2014 was not significant (OR = 1.02, 95% CI [0.66, 1.55], p = 0.942) but
84% more likely in 2015 (OR = 1.84, 95% CI [1.18, 2.87], p = 0.007) compared to
treatment completion rate in 2013.
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Multiple Regression Analysis of Patient Characteristics in Urban Freetown
The results of a multiple logistic analysis of patient characteristics receiving
treatment in the urban DOTS center are presented in Table 8. The total number of cases
with no missing data in the analysis was 875. The results of the regression analysis
indicate that HIV status, marital status, educational level, and year of treatment were
significant in predicting treatment completion among TB patients receiving treatment in
DOTS center in the urban area (see Table 8). The odds ratio of the likelihood for
treatment completion among HIV – positive TB patients was 44% less likely compared to
HIV – negative patients., OR = 0.66, 95% CI (0.52, 0.94), p = 0.022.
It is interesting to note that marital status is a significant predictor of TB treatment
completion among urban residents. The odds of the likelihood of treatment completion
increased by 52% among those that were married compared to those that were not
married, OR = 1.52, 95% CI (1.09, 2.13), p = 0.015. The results further showed that
treatment completion was only significant for secondary and post-education education in
urban areas. Even though treatment completion improved with education, having
secondary education was the threshold for completing treating in urban area. The OR for
the two educational levels compared with no education were OR = 4.68, 95% CI (0.95,
2.31), p = 0.0001 and OR = 3.34, 95% CI (1.94, 5.74), p = 0.0001.
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Table 8
Stratified Multiple Logistic Regression Analysis of Treatment Completion (Urban) with
Odds ratio (OR), 95% CI, Wald and P values (N= 875)
%a

OR

13.37

1.00

58.86
21.83
5.94

1.28
1.64
1.08

34.74

1.00

65.26

Non-new
New

Variable

95% CI
Lower
Upper

Wald

P

0.80
0.93
0.51

2.06
2.89
2.32

1.06
2.95
0.04

0.302
0.086
0.838

1.30

0.94

1.80

2.46

0.117

11.20
88.80

1.00
0.87

0.53

1.42

0.31

0.580

HIV/TB
status
Negative
Positive

75.20

1.00

24.80

0.66

0.46

0.94

5.24

0.022

Marital status
Not married
Married

60.69

1.00

39.31

1.52

1.09

2.13

5.96

0.015

25.83
27.77

1.00
1.42

0.95

2.13

2.89

0.089

32.57

4.68

2.99

7.33

45.48

0.000

13.83

3.34

1.94

5.74

18.93

0.000

Age category
0–20 yrs
21–40 yrs
41–60 yrs
≥ 61 yrs
Gender
Female
Male
TB-case category

Educational level
None
Some
primary/primary
education
Secondary
education
Postsecondary
education

…………………………………...………………………………………..(table continues)
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Variable

%a

OR

95% CI
Lower
Upper

Wald

P

Year
35.09
1.00
2013
34.51
2014
1.87
1.32
2.66
12.30
0.000
30.40
2015
2.93
2.00
4.30
30.10
0.000
a
Nonmissing percent frequencies of covariates in the logistic regression model
Table 8 also shows that the likelihood of treatment completion improved over the
years. The odds ratio of the likelihood of treatment completion improved by 87% in 2014
and 193% in 2015 when compared with 2013 respectively. The age, TB-case category,
and the gender of the patient were not significant variables in predicting TB treatment
completion in the urban area. It can be concluded that HIV status, marital status,
educational level, and year of treatment are significant in improving treatment completion
rates among urban patients.
Summary
The analysis and results of a retrospective data collected on patients registered for
TB treatment in four DOTS centers between 2013 through 2015 was discussed in the
preceding sections. In this I examined four independent variables (age, gender, TB-case
category, and HIV status), one categorical variable (treatment completion) and three
covariates (marital status, education, and location). Univariate analysis was conducted to
examine the predictive ability of each independent variable on the outcome variable. This
was followed by multivariate logistic regression analysis to control for the contributory
effect of other covariates.
I investigated four RQs with their attendant hypothesis. The aim of RQ 1 was to
examine the association between age and treatment completion while controlling for
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marital status, education, and location. Based on the results, I rejected the alternative
hypothesis of an association between age and treatment completion and accepted the null
hypothesis that there was no association between age and treatment completion when
controlling for marital status, education, and location.

In R Q 2, I tested the extent to which gender can predict treatment completion
among TB patients. There was no significant difference in the likelihood of treatment
completion among males when compared with females. Therefore, gender is not a good
predictor of treatment completion.
RQ 3 examined the association between TB-case category and treatment
completion. No significant difference was observed in the odds of completing treatment
among those that were new cases compared with non-new cases.
RQ 4 examined the extent to which HIV status predicts the odds of treatment
completion and TB patients. The results of the analysis supported the alternative
hypothesis of that there is a difference in the odds of treatment completion between HIV–
Positive and HIV–Negative patients.
My results also indicated that the level of education and the year in which
treatment was administered predicted the odds of the likelihood of treatment completion.
The overall result showed that program performance improved over time as the
proportion of those that did not complete their treatment significantly decreased with
time.
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This chapter is followed by Chapter 5 where I will discuss the results of the
investigation. I will also interpret the results as it relates to the literature and general
public health practice. I will give some recommendations relevant to improve treatment
outcomes, as well as areas of for further research studies.
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Chapter 5 Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to identify key patient characteristics that will
predict TB treatment completion among TB patients enrolled in the DOTS program in
Sierra Leone. Many factors are believed to affect patient’s ability to engage fully in the
utilization of the DOTS program for the treatment of TB, including patient
characteristics, availability of drugs, availability of personnel to directly administer the
program tenets, HIV prevalence, stigma, and early diagnosis (Vijay et al., 2010).
Therefore, I conducted a retrospective cohort study to investigate how patient
characteristics affect treatment completion among TB patients in Sierra Leone. Data were
extracted from patient records from four DOTS centers in the country (Bo, Freetown,
Makeni, and Kenema). The DOTS centers were chosen to represent the four
administrative divisions in the country.
Summary of Key Findings
The results of my analysis of the data showed that a majority of the TB patients
(55%) were between the ages of 21 to 40 years with a mean age of 34.18 years, mostly
male (63%), not married (60%), were HIV-negative (78%) and presented with new TB
cases (89%). With the exception of TB-case category, age, gender, and HIV status were
considered significant predictors of TB treatment completion among TB patients in a
bivariate analysis. However, a logistic regression analysis of the data failed to establish
any significant predictive ability of age, gender and TB-case category on treatment
completion but confirmed that HIV status was a significant predictor of TB treatment
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completion. The OR of the likelihood of treatment completion was significantly lower
among HIV-positive patients compared to those that were HIV-negative. The results also
showed significant differences in the odds of the likelihood of treatment when the
educational level of the patient, treatment location, and year of treatment were taken into
account.
Interpretation of the Findings
My specific objective with this study was to investigate whether patients’ age,
gender, TB-case category, and HIV status affects treatment completion among TB
patients while controlling for education, marital status, and location. I hypothesized that
there was no significant association between TB treatment completion and age or TBcase category. The results indicated that the null hypothesis could not be rejected, and
therefore treatment completion had no significant association with age or TB-case
category. I also hypothesized that there was no difference in the OR of TB treatment
completion between men and women or between HIV-positive patients and HIV-negative
patients. The result of the study showed that the odds of the likelihood of TB treatment
completion were not statistically different between men and women, but the likelihood of
TB treatment completion declined among HIV-positive patients when compared with
HIV-negative patients.
Interpretation of the Findings With Relation to the Literature
RQ1. With the first research question, I tested the existence of an association
between age and TB treatment completion. The OR from the logistic regression analysis
was not significant (p > 0.05). The odds of the likelihood of treatment completion was
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not significant among any of the age groups. The result showed that there was no
significant association between TB treatment completion and age while holding all other
variables constant. This means that TB treatment completion was not affected by age.
This finding was in agreement with results obtained by Endris et al. (2014).
Endris et al. reported that there was significant association between age and unsuccessful
treatment outcome. However, the result of their study should be interpreted with caution
as the sample size was significantly small (417) to give a stronger statistical power.
The findings of this study with regards to age and treatment outcome are in
contradiction with several other studies (e.g., Demeke et al., 2013; Hamusse et al., 2014;
Syed, 2014). Demeke et al (2013) observed that the OR for treatment success decreased
with age. In their study, patients in the age group greater than 15 years old were
significantly less likely to have successful treatment outcome compared to those that
were less than 15 years old. Similar results were reported by Hamusse et al. (2014), who
indicated that age groups 25–49 and ≥ 50 years were significantly associated with
unsuccessful treatment outcomes. The findings of both studies can be explained by the
fact that as patients age, their immunity declines, and therefore, they are easily prone to
be overwhelmed with opportunistic infections such as TB. The differences in the
outcome between this study and those of Hamusse et al. can be attributed partially to
sample size. Hamusse et al. used a large sample size of 14,221 compared to 1,633 cases
in this study. But this does not hold true in the case of Syed (2014) and Demeke et al.
who used 609 and 2,303 cases respectively.
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RQ2. With the second research question, I examined the extent to which gender
can predict treatment completion among TB patients in Sierra Leone. I hypothesized that
there was no significant difference in odds of treatment completion between men and
women among TB patients in Sierra Leone while holding other covariates constant. The
result of this study showed that the odds of treatment completion among men increased
by 14 % but was not statistically significant enough to make any difference in odds of
treatment completion between men and women. In general, men were more affected by
the TB disease than women, accounting for 63 % of all cases.
Even though the results of this study regarding gender are similar to the outcome
obtained by Endris et al. (2014), they are different from those arrived at by Gadoev et al.
(2015) and Jemal et al. (2015). These researchers opined that being male was associated
with negative treatment outcome.
RQ3. In developing RQ3, I set out to answer whether there is an association
between TB-case category and TB treatment completion. My null hypothesis of no
association between TB-case category and TB treatment completion was upheld based on
the results from the multivariate logistic regression. The majority of the TB cases were
new patients, but their odds of the likelihood of TB treatment completion were not
statistically different from those that were non-new cases. The findings in this study are
in contrast with studies undertaken by Gadoev et al. (2015) and Hamusse et al. (2014). In
a large retrospective study of 107,380 patients, Gadoev et al. found that patients that were
previously treated (non-new cases) were associated with loss-to-follow-up compared with
new cases. In a similar study, Hamusse et al. also concluded that retreatment cases were
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more associated with unsuccessful treatment than new cases.
RQ4. My aim with RQ4 was to investigate to what extent HIV status predicts the
odds of treatment completion among TB patients in Sierra Leone. The results of this
study showed that the prevalence of HIV among the TB subpopulation is far greater than
the general population. There were 19.4% of TB patients that were coinfected with HIV
compared to 1.5% in the general population. Among these cases, 43% did not complete
their treatment. The results of the multivariate analysis showed that the outcome was
statistically significant. The odds of treatment completion among HIV-positive cases was
38% less likely compared to those that were HIV–negative. This result was in conformity
with results obtained by Hamusse et al. (2014), Gadoeve et al. (2015), and Jemal et al.
(2015). This study had a similar outcome with what Jemal et al. concluded in their study.
The result of their study showed that 20% of TB patients were coinfected with HIV and
that being HIV-positive negatively affected treatment success rate. In a similar study,
conducted by Gadoeve et al. to investigate risk factors associated with unfavorable
treatment outcome, the authors concluded that being HIV-positive was associated with
death, loss-to-follow-up, and treatment failure. This finding was further supported by the
findings of Hamusse et al. who also concluded in their study that TB/HIV coinfection
was associated with unsuccessful treatment outcome.
The conclusions from these findings can be put into perspective. The lack of
association between age, gender, and TB-case category as opposed to what generally
exists in the literature can be partly attributed to sample size. It is probable that the
sample size I used in this study was not large enough to capture any significant
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differences that would support the alternative hypothesis in favor of null hypothesis.
Therefore, it is prudent that future researchers should consider increasing the sample to
have a clearer picture of the impact of these variables on treatment completion.
It is no surprise that being HIV-positive negatively affects treatment completion
as concluded in this study. It has been widely reported that HIV weakens the immune
system, and therefore, provides the right environment for opportunistic infections like TB
to thrive (Gordin & Masur, 2012). The HIV epidemic has accelerated the resurgence of
TB in societies where latent TB is endemic( Gordin & Masur, 2012). Patients infected
with HIV have a 50% chance of reactivating latent TB compared to only a 10% chance
among HIV-negative patients (Nyamogoba et al., 2012). It is believed that HIV infection
is the greatest risk factor for new TB infection and also has the most significant potential
for TB recurrence (Nyamogoba et al., 2012). This does not address the question of why
HIV/TB coinfected patients fail to utilize the available sources in the form of DOTS
program to complete their treatment though. It can be argued that once TB patients find
out that they are HIV-positive, they lose hope and tend to resign altogether in life and
refuse to continue treatment. This is particularly true in scenarios where proper
counseling is lacking that would educate patients about the benefits of the treatment.
Efforts should be accelerated to educate patients that both diseases can be treated or
managed and that they still have the chance to live a higher quality and productive life.
Covariates. The results of this study showed that education, location, and year of
treatment had a significant impact on treatment completion. Education was shown to be a
major predictor of treatment completion, especially in rural areas. Similar conclusions
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were arrived at by Syed (2014), who identified rural residency and illiteracy as having a
significant association with treatment failure. Sunday et al. (2014) also concluded that the
location where patients received their treatment had a significant association with
favorable treatment outcome.
The results from this study showed that as the level of education increases, the
odds of treatment completion improves by eight-fold in the rural areas compared to those
who had no education. The results did not reveal a dramatic increase in odds of treatment
completion beyond secondary level in urban centers. It was apparent that acquiring
secondary education in an urban environment is the threshold required for enhanced
participation in the DOTS program. This can be attributed to the fact that urban residents
are inundated with information through various sources such as radio, television, and
Internet which might be lacking in rural areas. Therefore, urban residents are better
equipped with information about services outside the academic sphere.
The results of this study also demonstrated that overall treatment performance
improved over the years. The number of patients that dropped out of the DOTS treatment
program almost reduced to half from 44 % in 2013 to 24 % in 2015. The OR for
treatment completion increased by 1.48-fold in 2014 to 2.41-fold in 2015 compared to
2013. The result was even better in the urban area which improved three- fold in 2015.
It seems that there was an improvement in DOTS program performance in 2015
despite the ebola epidemic in 2014 through 2015, which decimated the health care
infrastructure in the country. This could be explained by the fact that the government, in
its effort to meet the target set by Millennium Development Goals for TB in 2015, had
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already put in place resources and strategies to improve program performance before the
ebola outbreak. The MOHS developed treatment guidelines that integrated TB and HIV
treatment in a package. They also trained community health workers that were solely
responsible for increasing awareness about TB disease and to monitor quality indicators
for service delivery. The MOHS also partnered with the World Food Program to provide
nutritional support services to highly malnourished HIV and TB patients in vulnerable
communities. The overall effect of these efforts was an improvement in DOTS program
performance by a reduction in dropout rates among TB patients in 2015.
Interpretation of the Findings in the Context of the Theoretical Framework
The theoretical framework for this study was based on the Andersen’s behavioral
model of health services utilization. The model posits that health services utilization is
influenced by predisposing factors, enabling factors, and need factors (Kim, et al., 2010).
In this study, I used mainly the predisposing factors that predict DOTS utilization in the
completion of TB treatment. The predisposing factors that were considered in this study
were patient’s age, gender, marital status, and location of treatment. The predisposing
factors considered in this study were not significantly associated with service utilization,
which is in direct contrast with what is predicted by Andersen’s model. According to
several studies using Andersen’s model, education (an enabling factor) is perceived to
have a direct relationship with service utilization. The results in this study also confirmed
that education was significantly associated with treatment completion among TB patients.
The need factors addressed in this study were TB-case category and HIV status. Patients
who think that their health conditions are poor were significantly more likely to receive
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treatment for their condition than those who believe that they are in excellent health. I did
not find any significant difference in service utilization among patients who had new TB
cases from those that were retreated, defaulted, or failed treatment the first time around.
However, HIV-positive TB patients were less likely to complete their treatment than their
HIV-negative counterparts.
The model, however, did not address the trend in service utilization as depicted by
the rate of treatment completion. It is evident from the result that treatment improved
over time significantly. It can be argued that the main RQs did not include trend.
However, the results have shown that the observed trend cannot be ignored in the final
discussion. In that respect, the traditional epidemiological triad of person, place and time
could have provided an inclusive model to interpret the results in its entirety. The person
in the epidemiologic triad is the characteristics of the TB patients such as age, gender,
marital status, education, TB-case category, and HIV status. One essence of program
evaluation is to improve performance over time. Therefore, the time variable in this study
is relevant. The place is the DOTS location where treatments were administered. From
the result, treatment completion is affected by one patient characteristic (HIV) and that
treatment completion is affected by the location which improved over time.
Limitations of the Study
As has been stated earlier, I conducted the study in only four DOTS centers in
Sierra Leone that treated patients between the periods 2013 through 2015. It does not
include data on the more than 100 DOTS centers across the country. The research is
limited to only those centers and the period stated. It is possible that patients attending
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other DOTS centers might have different treatment outcomes on patient characteristics.
The results in this study may therefore not be a representative of the entire TB patient
population in the country. This will pose a threat to eternal valid of the outcome.
The use of secondary data in itself poses limitations as I did not defined or
recorded the variables.. There is potential for the introduction of errors in the record
which is beyond the control of the researcher. Also, patient records indicate that some
patients were transferred out but there was no way to track those patients. Some records
also contained missing patient information that made it impossible to include them in the
analysis. Because of that the records of patients that were transferred out and those with
missing information were eliminated from the final analysis.
Recommendations
Robust program implementation should include program evaluation. Program
evaluation helps to highlight efficacies and shortcomings in the implementation process.
The MOHSshould engage in evidence-based activities through research to better
understand trends in the implementation of the DOTS program. Such events will provide
a blueprint for the surveillance of TB transmission in the country. In order to build a
better surveillance system, proper attention should be dedicated to data collection,
management, and storage. There was no consistent pattern in the way data is collected
and stored from one DOTS center to the other. Once patients complete their treatment or
drop-out of the program, patient hospital records were haphazardly stored all over the
place. Several variables were incomplete in the patient’s records. The MOHS should
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dedicate resources to training staff in data handling and storage. This will be assistance in
future research that is low cost, and enhance surveillance of the TB disease.
This study was undertaken in only four DOTS centers in the country. The
reported treatment completion rate of about 66% in this study was far below the
government reported treatment success rate of 88%. It is recommended that follow-up
research be undertaken that covers the entire country to provide a comprehensive analysis
of the DOTS program. Another area of research that is recommended is to look at the
impact of socioeconomic status, and access to health care especially with regards to
transportation or distance from the DOTS centers. The prevalence of MDR-TB and its
impact on treatment outcome should also be considered for further research.
Furthermore, the HIV prevalence rate in this study raises an alarm bell in the fight
against the disease. It seems that the government reported prevalence rate far more
underestimates the actual scenario in the country. It is therefore recommended that
detailed study be instituted to help understand the actual threat level of HIV in the
country. The MOHS should assign case managers to patients that have the potential to
drop out od the program such as HIV/TB patients in order to improve on program
performance. The rural communities should be educated about the availability of the
treatment for TB.
Social Change Implications
This study is among a very few evidence-based studies that had been undertaken
to assess the implementation of DOTS program in the treatment of TB in Sierra Leone
after decades of its implementation. In that regard, it provides valuable literature that is
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useful to policymakers, healthcare professionals, and scientists or researchers on the
DOTS program in Sierra Leone. It is evident from the study that HIV still remains a
significant public health threat in Sierra Leone. It is not only due to the suspected
increase in the prevalence of HIV, but also the negative impact it had on TB treatment.
Therefore, DOTS program implementers should refocus their attention on this subset of
the TB population to help improve on program performance.
It is also noted in this study that education and residency impact treatment
completion. Patients in rural communities are more likely not to complete their treatment
than residents in urban areas. It seems that education in rural communities is a major
factor that increases the likelihood of treatment completion, whereas in urban centers,
acquiring a secondary education is the threshold for maximum participation. This might
be because residents in the urban area receive information about government programs
such as DOTS from different sources outside of formal education whereas residents in
the rural areas receive their information mainly through formal education. Unfortunately,
the illiteracy rate in the rural communities is far greater than those in the urban
communities. The government should, therefore, concentrate resources on information
dissemination about various health programs including DOTS in rural communities.
These communities do not have the many access to information such as internet, cable
television, phone applications, and radio that urban residents enjoy.
Conclusion
The results of this study showed that the majority of those suffering from TB were
young uneducated or semieducated, unmarried males under 40 years old. About 19.4% of
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TB patients were coinfected with HIV which is far above the national prevalence of 1.5%
of the HIV disease. This trend, if not addressed, will pose a major threat to the successful
implementation of DOTS program in the treatment of TB as HIV-positive patients were
less likely to complete their treatment. The results failed to identify other patient
characteristics such age, gender, and TB category as predictors of treatment compliance.
However, education seems to play a major role in treatment completion which tends to
improve over time.
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